CN114716345A - Method for deoxygenation functionalization and deoxygenation activation of alcohols and alcohol-functionalized materials - Google Patents
Method for deoxygenation functionalization and deoxygenation activation of alcohols and alcohol-functionalized materials Download PDFInfo
- Publication number
- CN114716345A CN114716345A CN202110014657.3A CN202110014657A CN114716345A CN 114716345 A CN114716345 A CN 114716345A CN 202110014657 A CN202110014657 A CN 202110014657A CN 114716345 A CN114716345 A CN 114716345A
- Authority
- CN
- China
- Prior art keywords
- alcohol
- substituted
- unsubstituted
- solvent
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 64
- 230000004913 activation Effects 0.000 title claims abstract description 14
- 238000006392 deoxygenation reaction Methods 0.000 title claims abstract description 8
- 238000007306 functionalization reaction Methods 0.000 title claims description 25
- 239000000463 material Substances 0.000 title claims 4
- 150000001298 alcohols Chemical class 0.000 title description 7
- 239000002904 solvent Substances 0.000 claims abstract description 143
- 239000012038 nucleophile Substances 0.000 claims abstract description 135
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 120
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims abstract description 110
- 239000012190 activator Substances 0.000 claims abstract description 25
- 230000003213 activating effect Effects 0.000 claims abstract description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 228
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 108
- 150000001875 compounds Chemical class 0.000 claims description 89
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Chemical compound C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 claims description 82
- 125000003118 aryl group Chemical group 0.000 claims description 54
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical class SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 claims description 45
- 125000000217 alkyl group Chemical group 0.000 claims description 44
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 40
- 150000001412 amines Chemical class 0.000 claims description 37
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 36
- 229910052717 sulfur Inorganic materials 0.000 claims description 36
- 239000011593 sulfur Substances 0.000 claims description 36
- 229910052736 halogen Inorganic materials 0.000 claims description 33
- 150000002367 halogens Chemical class 0.000 claims description 33
- -1 azide salts Chemical class 0.000 claims description 31
- 125000001424 substituent group Chemical group 0.000 claims description 31
- 229910052760 oxygen Inorganic materials 0.000 claims description 28
- 239000000047 product Substances 0.000 claims description 28
- 125000003545 alkoxy group Chemical group 0.000 claims description 27
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 27
- 239000001301 oxygen Substances 0.000 claims description 27
- 125000001072 heteroaryl group Chemical group 0.000 claims description 21
- 230000003287 optical effect Effects 0.000 claims description 17
- 238000005987 sulfurization reaction Methods 0.000 claims description 12
- 238000005576 amination reaction Methods 0.000 claims description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 125000005233 alkylalcohol group Chemical group 0.000 claims description 8
- 239000007795 chemical reaction product Substances 0.000 claims description 8
- 238000006266 etherification reaction Methods 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 8
- 230000032050 esterification Effects 0.000 claims description 7
- 238000005886 esterification reaction Methods 0.000 claims description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- 125000003277 amino group Chemical group 0.000 claims description 6
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 150000001540 azides Chemical class 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- NNRANHIFAQDLRA-UHFFFAOYSA-N iodo(triphenyl)silane Chemical compound C=1C=CC=CC=1[Si](C=1C=CC=CC=1)(I)C1=CC=CC=C1 NNRANHIFAQDLRA-UHFFFAOYSA-N 0.000 claims description 5
- 150000002989 phenols Chemical class 0.000 claims description 5
- 150000003139 primary aliphatic amines Chemical class 0.000 claims description 5
- 150000003142 primary aromatic amines Chemical class 0.000 claims description 5
- 150000003336 secondary aromatic amines Chemical class 0.000 claims description 5
- 150000001408 amides Chemical class 0.000 claims description 4
- 150000005619 secondary aliphatic amines Chemical class 0.000 claims description 4
- CHLCPTJLUJHDBO-UHFFFAOYSA-M sodium;benzenesulfinate Chemical compound [Na+].[O-]S(=O)C1=CC=CC=C1 CHLCPTJLUJHDBO-UHFFFAOYSA-M 0.000 claims description 4
- 229940124530 sulfonamide Drugs 0.000 claims description 4
- 150000003456 sulfonamides Chemical class 0.000 claims description 4
- WXZOJKGGVNTBBY-UHFFFAOYSA-N tricyclohexyl(iodo)silane Chemical compound C1CCCCC1[Si](C1CCCCC1)(I)C1CCCCC1 WXZOJKGGVNTBBY-UHFFFAOYSA-N 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical class [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 claims description 3
- ODGTVVCTZIKYTG-UHFFFAOYSA-N tert-butyl-iodo-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)I ODGTVVCTZIKYTG-UHFFFAOYSA-N 0.000 claims description 3
- RYHGFALZTBTGDK-UHFFFAOYSA-N tributyl(iodo)silane Chemical compound CCCC[Si](I)(CCCC)CCCC RYHGFALZTBTGDK-UHFFFAOYSA-N 0.000 claims description 3
- FUGWOYOEVNYBJX-UHFFFAOYSA-N tritert-butyl(iodo)silane Chemical compound CC(C)(C)[Si](I)(C(C)(C)C)C(C)(C)C FUGWOYOEVNYBJX-UHFFFAOYSA-N 0.000 claims description 3
- 230000009435 amidation Effects 0.000 claims description 2
- 238000007112 amidation reaction Methods 0.000 claims description 2
- 238000003763 carbonization Methods 0.000 claims description 2
- 150000007942 carboxylates Chemical class 0.000 claims description 2
- 230000026030 halogenation Effects 0.000 claims description 2
- 238000005658 halogenation reaction Methods 0.000 claims description 2
- 125000002346 iodo group Chemical group I* 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 230000003635 deoxygenating effect Effects 0.000 claims 2
- DNAPJAGHXMPFLD-UHFFFAOYSA-N triiodosilane Chemical compound I[SiH](I)I DNAPJAGHXMPFLD-UHFFFAOYSA-N 0.000 claims 2
- 239000012434 nucleophilic reagent Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 19
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 171
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 136
- 238000005481 NMR spectroscopy Methods 0.000 description 75
- 229910052786 argon Inorganic materials 0.000 description 68
- 238000004440 column chromatography Methods 0.000 description 36
- 238000002360 preparation method Methods 0.000 description 36
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 31
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 28
- 239000006227 byproduct Substances 0.000 description 13
- 239000011734 sodium Substances 0.000 description 11
- 239000002994 raw material Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methyl-N-phenylamine Natural products CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- LRPTXRCORNOMTB-UHFFFAOYSA-N [SiH4].I Chemical compound [SiH4].I LRPTXRCORNOMTB-UHFFFAOYSA-N 0.000 description 3
- 125000002015 acyclic group Chemical group 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 2
- LBUJPTNKIBCYBY-UHFFFAOYSA-N 1,2,3,4-tetrahydroquinoline Chemical compound C1=CC=C2CCCNC2=C1 LBUJPTNKIBCYBY-UHFFFAOYSA-N 0.000 description 2
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 2
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- 238000006677 Appel reaction Methods 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000006751 Mitsunobu reaction Methods 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- OJGMBLNIHDZDGS-UHFFFAOYSA-N N-Ethylaniline Chemical compound CCNC1=CC=CC=C1 OJGMBLNIHDZDGS-UHFFFAOYSA-N 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 2
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical compound CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 description 2
- AUONHKJOIZSQGR-UHFFFAOYSA-N oxophosphane Chemical compound P=O AUONHKJOIZSQGR-UHFFFAOYSA-N 0.000 description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- 229940031826 phenolate Drugs 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- SUVIGLJNEAMWEG-UHFFFAOYSA-N propane-1-thiol Chemical compound CCCS SUVIGLJNEAMWEG-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 150000003333 secondary alcohols Chemical class 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- LKYIPGJOXSVWPX-UHFFFAOYSA-M sodium;thiophene-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1=CC=CS1 LKYIPGJOXSVWPX-UHFFFAOYSA-M 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- PPLMQFARLJLZAO-UHFFFAOYSA-N triethyl(iodo)silane Chemical compound CC[Si](I)(CC)CC PPLMQFARLJLZAO-UHFFFAOYSA-N 0.000 description 2
- AAPLIUHOKVUFCC-UHFFFAOYSA-N trimethylsilanol Chemical compound C[Si](C)(C)O AAPLIUHOKVUFCC-UHFFFAOYSA-N 0.000 description 2
- 238000004073 vulcanization Methods 0.000 description 2
- GDWRKZLROIFUML-VIFPVBQESA-N (2s)-4-phenylbutan-2-ol Chemical compound C[C@H](O)CCC1=CC=CC=C1 GDWRKZLROIFUML-VIFPVBQESA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- QZZBJCFNHPYNKO-UHFFFAOYSA-N 1-Phenylethane-1-thiol Chemical compound CC(S)C1=CC=CC=C1 QZZBJCFNHPYNKO-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- WKTSFRBEJWLNKI-UHFFFAOYSA-N 1-phenylpropane-1-thiol Chemical compound CCC(S)C1=CC=CC=C1 WKTSFRBEJWLNKI-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 1
- AKCRQHGQIJBRMN-UHFFFAOYSA-N 2-chloroaniline Chemical compound NC1=CC=CC=C1Cl AKCRQHGQIJBRMN-UHFFFAOYSA-N 0.000 description 1
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 1
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- PRNFUXYRTWHXNG-UHFFFAOYSA-N 2-iodo-2,3-dimethylbutane Chemical compound CC(C)C(C)(C)I PRNFUXYRTWHXNG-UHFFFAOYSA-N 0.000 description 1
- JBIJLHTVPXGSAM-UHFFFAOYSA-N 2-naphthylamine Chemical compound C1=CC=CC2=CC(N)=CC=C21 JBIJLHTVPXGSAM-UHFFFAOYSA-N 0.000 description 1
- ASZZHBXPMOVHCU-UHFFFAOYSA-N 3,9-diazaspiro[5.5]undecane-2,4-dione Chemical compound C1C(=O)NC(=O)CC11CCNCC1 ASZZHBXPMOVHCU-UHFFFAOYSA-N 0.000 description 1
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 1
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 1
- LYUQWQRTDLVQGA-UHFFFAOYSA-N 3-phenylpropylamine Chemical compound NCCCC1=CC=CC=C1 LYUQWQRTDLVQGA-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- WXNZTHHGJRFXKQ-UHFFFAOYSA-N 4-chlorophenol Chemical compound OC1=CC=C(Cl)C=C1 WXNZTHHGJRFXKQ-UHFFFAOYSA-N 0.000 description 1
- LHWZLUXODWUHLZ-UHFFFAOYSA-N 4-methyl-n-(4-methylphenyl)sulfonylbenzenesulfonamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NS(=O)(=O)C1=CC=C(C)C=C1 LHWZLUXODWUHLZ-UHFFFAOYSA-N 0.000 description 1
- GDWRKZLROIFUML-UHFFFAOYSA-N 4-phenylbutan-2-ol Chemical compound CC(O)CCC1=CC=CC=C1 GDWRKZLROIFUML-UHFFFAOYSA-N 0.000 description 1
- AGNFWIZBEATIAK-UHFFFAOYSA-N 4-phenylbutylamine Chemical compound NCCCCC1=CC=CC=C1 AGNFWIZBEATIAK-UHFFFAOYSA-N 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- ITIONVBQFUNVJV-UHFFFAOYSA-N Etomidoline Chemical compound C12=CC=CC=C2C(=O)N(CC)C1NC(C=C1)=CC=C1OCCN1CCCCC1 ITIONVBQFUNVJV-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N N-phenyl amine Natural products NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- SCHRRICRQNJJKN-UHFFFAOYSA-N P.[O] Chemical compound P.[O] SCHRRICRQNJJKN-UHFFFAOYSA-N 0.000 description 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000004280 Sodium formate Substances 0.000 description 1
- 239000005991 Sodium o-nitrophenolate Substances 0.000 description 1
- 239000005992 Sodium p-nitrophenolate Substances 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 1
- NDEHZONFJLYJEH-SECBINFHSA-N [(3r)-3-iodobutyl]benzene Chemical compound C[C@@H](I)CCC1=CC=CC=C1 NDEHZONFJLYJEH-SECBINFHSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- UKFWSNCTAHXBQN-UHFFFAOYSA-N ammonium iodide Chemical compound [NH4+].[I-] UKFWSNCTAHXBQN-UHFFFAOYSA-N 0.000 description 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000002178 anthracenyl group Chemical group C1(=CC=CC2=CC3=CC=CC=C3C=C12)* 0.000 description 1
- 125000000477 aza group Chemical group 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- UENWRTRMUIOCKN-UHFFFAOYSA-N benzyl thiol Chemical compound SCC1=CC=CC=C1 UENWRTRMUIOCKN-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- WQAQPCDUOCURKW-UHFFFAOYSA-N butanethiol Chemical compound CCCCS WQAQPCDUOCURKW-UHFFFAOYSA-N 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 229940125810 compound 20 Drugs 0.000 description 1
- 229940126086 compound 21 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940125898 compound 5 Drugs 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000002190 fatty acyls Chemical group 0.000 description 1
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- SQEHCNOBYLQFTG-UHFFFAOYSA-M lithium;thiophene-2-carboxylate Chemical compound [Li+].[O-]C(=O)C1=CC=CS1 SQEHCNOBYLQFTG-UHFFFAOYSA-M 0.000 description 1
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical group CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N mono-n-propyl amine Natural products CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004888 n-propyl amino group Chemical group [H]N(*)C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- PCZSPVPUWRXJLD-UHFFFAOYSA-M potassium;thiophene-2-carboxylate Chemical compound [K+].[O-]C(=O)C1=CC=CS1 PCZSPVPUWRXJLD-UHFFFAOYSA-M 0.000 description 1
- 125000000075 primary alcohol group Chemical group 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 1
- 235000019254 sodium formate Nutrition 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- 229940006198 sodium phenylacetate Drugs 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- AXKBOWBNOCUNJL-UHFFFAOYSA-M sodium;2-nitrophenolate Chemical compound [Na+].[O-]C1=CC=CC=C1[N+]([O-])=O AXKBOWBNOCUNJL-UHFFFAOYSA-M 0.000 description 1
- FXZLBDIGNGMDOK-UHFFFAOYSA-M sodium;3,5-difluorobenzoate Chemical compound [Na+].[O-]C(=O)C1=CC(F)=CC(F)=C1 FXZLBDIGNGMDOK-UHFFFAOYSA-M 0.000 description 1
- VZGYROLJKOBEOF-UHFFFAOYSA-M sodium;4-methylthiophene-2-carboxylate Chemical compound [Na+].CC1=CSC(C([O-])=O)=C1 VZGYROLJKOBEOF-UHFFFAOYSA-M 0.000 description 1
- CURNJKLCYZZBNJ-UHFFFAOYSA-M sodium;4-nitrophenolate Chemical compound [Na+].[O-]C1=CC=C([N+]([O-])=O)C=C1 CURNJKLCYZZBNJ-UHFFFAOYSA-M 0.000 description 1
- RCOSUMRTSQULBK-UHFFFAOYSA-N sodium;propan-1-olate Chemical compound [Na+].CCC[O-] RCOSUMRTSQULBK-UHFFFAOYSA-N 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ZVQXQPNJHRNGID-UHFFFAOYSA-N tetramethylsuccinonitrile Chemical compound N#CC(C)(C)C(C)(C)C#N ZVQXQPNJHRNGID-UHFFFAOYSA-N 0.000 description 1
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/08—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated
- C07C247/10—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being unsaturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明涉及有机合成领域,公开了一种将醇进行脱氧官能化和脱氧活化的方法与醇官能化物质,该方法包括:(1)在第一溶剂中,在活化剂存在下,将醇进行脱氧活化,得到碘代物中间体;(2)在第二溶剂中,在亲核试剂存在下,将所述碘代物中间体进行官能化。本发明提供的方法操作简便、易于分离纯化。The invention relates to the field of organic synthesis, and discloses a method for deoxidizing and deoxidizing and activating alcohol and an alcohol-functionalized substance. The method comprises: (1) in a first solvent, in the presence of an activator, the alcohol is Activation by deoxygenation yields the iodide intermediate; (2) functionalizing the iodide intermediate in a second solvent in the presence of a nucleophile. The method provided by the invention is easy to operate and easy to separate and purify.
Description
技术领域technical field
本发明涉及有机合成领域,具体涉及将醇进行脱氧官能化和脱氧活化的方法与醇官能化物质。The invention relates to the field of organic synthesis, in particular to a method for deoxyfunctionalizing and deoxyactivating alcohol and an alcohol functionalized substance.
背景技术Background technique
作为一类廉价易得的化合物,醇的脱氧官能化一直是有机合成化学、药物化学等领域的研究热点。根据反应过程中化学键的断裂形成方式,醇的脱氧官能化主要分为极化反应过程(Tetrahedron Lett.1980,21,801-804;Synlett 2019,30,1508-1524)、自由基反应过程(Tetrahedron Lett.1985,26,757-760;J.Am.Chem.Soc.2020,142,16787-16794)和金属催化反应过程(J.Am.Chem.Soc.2012,134,14638-14641;Chem.Commun.2015,51,2683-2686)。As a class of inexpensive and readily available compounds, the deoxyfunctionalization of alcohols has always been a research hotspot in the fields of organic synthetic chemistry and medicinal chemistry. According to the formation method of chemical bond breaking during the reaction process, the deoxyfunctionalization of alcohols is mainly divided into polarization reaction process (Tetrahedron Lett. 1985, 26, 757-760; J.Am.Chem.Soc.2020,142,16787-16794) and metal-catalyzed reaction process (J.Am.Chem.Soc.2012,134,14638-14641; Chem.Commun.2015, 51, 2683-2686).
其中,直接亲核取代是最理想的方式,H2O作为唯一的副产物,兼具环境友好和原子经济性的优点。但羟基作为不易离去基团,醇的直接亲核取代官能化难以进行,需要先对醇进行活化。Among them, direct nucleophilic substitution is the most ideal way, and H 2 O, as the only by-product, has the advantages of both environmental friendliness and atom economy. However, as the hydroxyl group is not easy to leave, the direct nucleophilic substitution functionalization of the alcohol is difficult, and the alcohol needs to be activated first.
传统试剂包含二氯亚砜、磺酰氯等可以对醇进行活化,但会产生计量强酸废弃物。Appel反应和Garegg–Samuelsson反应(J.Am.Chem.Soc.2007,129,9566-9567;J.Chem.Soc.,Perkin Trans.1 1980,2866-2869)是羟基卤代的有效方法,但使用高毒的CX4试剂或产生难以分离的膦氧副产物。Mitsunobu反应(Chem.Rev.2009,109,2551-2651)是醇脱氧官能化的常用方法,但其具有醇构型翻转的特性,并且其需要酸性的亲核试剂,对亲核试剂范围有所限制,且会产生计量难以分离的膦氧副产物,不符合原子经济性原则。Traditional reagents including thionyl chloride, sulfonyl chloride, etc. can activate alcohols, but will produce metered strong acid waste. The Appel reaction and the Garegg–Samuelsson reaction (J.Am.Chem.Soc. 2007, 129, 9566-9567; J. Chem. Soc., Perkin Trans. 1 1980, 2866-2869) are effective methods for hydroxyhalogenation, but Use highly toxic CX4 reagents or generate phosphine oxide by-products that are difficult to isolate. The Mitsunobu reaction (Chem. Rev. 2009, 109, 2551-2651) is a common method for the deoxyfunctionalization of alcohols, but it has the property of alcohol configuration inversion, and it requires an acidic nucleophile, which has some limitations on the range of nucleophiles. It also produces phosphine oxide by-products that are difficult to separate by measurement, which does not conform to the principle of atom economy.
因此,发展安全且易于操作和分离纯化的醇脱氧官能化方法具有重要意义。Therefore, it is of great significance to develop a method for the deoxyfunctionalization of alcohols that is safe and easy to operate and separate and purify.
发明内容SUMMARY OF THE INVENTION
本发明的目的是为了克服现有技术存在的上述缺陷,提供一种操作简便且易于分离纯化的醇脱氧官能化方法。The purpose of the present invention is to overcome the above-mentioned defects of the prior art, and to provide an alcohol deoxyfunctionalization method that is easy to operate and easy to separate and purify.
为了实现上述目的,本发明第一方面提供一种将醇进行脱氧官能化的方法,该方法包括:In order to achieve the above object, a first aspect of the present invention provides a method for deoxyfunctionalizing an alcohol, the method comprising:
(1)在第一溶剂中,在活化剂存在下,将醇进行脱氧活化,得到碘代物中间体;(1) in the first solvent, in the presence of an activator, the alcohol is deoxidized and activated to obtain an iodide intermediate;
(2)在第二溶剂中,在亲核试剂存在下,将所述碘代物中间体进行官能化,得到醇官能化物质;(2) in a second solvent, in the presence of a nucleophile, the iodide intermediate is functionalized to obtain an alcohol-functionalized substance;
其中,所述活化剂具有式(I)所示的结构;Wherein, the activator has the structure shown in formula (I);
其中,在式(I)中,Wherein, in formula (I),
Ra、Rb和Rc各自独立地选自取代或未取代的烷基、取代或未取代的芳基,且Ra、Rb和Rc中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R a , R b and R c are each independently selected from substituted or unsubstituted alkyl, substituted or unsubstituted aryl, and the optional substituents in R a , R b and R c are each independently selected from At least one of halogen, alkoxy, alkyl, aryl, heteroaryl, and amine.
本发明第二方面提供一种醇官能化物质,该物质选自以下化合物中的至少一种:A second aspect of the present invention provides an alcohol-functionalized substance selected from at least one of the following compounds:
本发明第三方面提供一种将醇进行脱氧活化的方法,该方法包括:A third aspect of the present invention provides a method for deoxidizing and activating alcohol, the method comprising:
在第一溶剂中,在活化剂存在下,将醇进行脱氧活化,所述活化剂具有式(I)所示的结构;In the first solvent, in the presence of an activator, the alcohol is deoxidized and activated, and the activator has the structure shown in formula (I);
其中,在式(I)中,Wherein, in formula (I),
Ra、Rb和Rc各自独立地选自取代或未取代的烷基、取代或未取代的芳基,且Ra、Rb和Rc中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R a , R b and R c are each independently selected from substituted or unsubstituted alkyl, substituted or unsubstituted aryl, and the optional substituents in R a , R b and R c are each independently selected from At least one of halogen, alkoxy, alkyl, aryl, heteroaryl, and amine.
与现有技术相比,本发明至少具有如下优势:Compared with the prior art, the present invention at least has the following advantages:
本发明提供的方法操作简便、易于分离纯化,并且本发明的方法底物适用范围更广,亲核试剂可选种类多,产物收率高,副产物少,产生的副产物(如硅醚、含碘盐)均能够蒸馏或水洗除去或回收利用,无酸废弃物生成,对环境无有害影响。The method provided by the present invention is easy to operate, easy to separate and purify, and the method of the present invention has a wider range of substrates, a wide range of optional nucleophiles, high product yield, few by-products, and generated by-products (such as silyl ether, Iodine-containing salts) can be distilled or washed to remove or recycled, no acid waste is generated, and no harmful impact on the environment.
特别地,本发明提供的方法,部分硫化产物和胺化产物能够保持反应原料底物醇的光学构型。In particular, the method provided by the present invention, the partially sulfided product and the aminated product can maintain the optical configuration of the reaction starting substrate alcohol.
本发明的其它特征和优点将通过随后的具体实施方式部分予以详细描述。Other features and advantages of the present invention will be described in detail in the detailed description section that follows.
具体实施方式Detailed ways
在本文中所披露的范围的端点和任何值都不限于该精确的范围或值,这些范围或值应当理解为包含接近这些范围或值的值。对于数值范围来说,各个范围的端点值之间、各个范围的端点值和单独的点值之间,以及单独的点值之间可以彼此组合而得到一个或多个新的数值范围,这些数值范围应被视为在本文中具体公开。The endpoints of ranges and any values disclosed herein are not limited to the precise ranges or values, which are to be understood to encompass values proximate to those ranges or values. For ranges of values, the endpoints of each range, the endpoints of each range and the individual point values, and the individual point values can be combined with each other to yield one or more new ranges of values that Ranges should be considered as specifically disclosed herein.
在本文中,针对以下术语先提供解释:In this article, explanations are provided for the following terms:
C1-20的烷基指碳原子总数为1-20(如1、2、3、4、5、6、7、8、9、10、11、12、13、14、15、16、17、18、19、20)个碳原子烷基的基团,可以为直链、支链或环状的烷基基团,包括但不限于甲基、乙基、正丙基、异丙基、正丁基、仲丁基、异丁基、叔丁基、正戊基、异戊基、新戊基、正己基、异己基、环己基等。C 1-20 alkyl refers to the total number of carbon atoms 1-20 (such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 , 18, 19, 20) alkyl groups of carbon atoms, which can be straight-chain, branched or cyclic alkyl groups, including but not limited to methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, isohexyl, cyclohexyl, etc.
C6-20的芳基指碳原子总数为6-20(如6、7、8、9、10、11、12、13、14、15、16、17、18、19、20)芳基的基团,包括但不限于苯基、萘基、蒽基等。Aryl of C 6-20 refers to an aryl group with a total number of carbon atoms of 6-20 (eg 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20). groups, including but not limited to phenyl, naphthyl, anthracenyl, and the like.
“C1-10的烷基”、“C6-15的芳基”、“C1-5的烷基”、“C6-10的芳基”与前述“C1-20的烷基”和“C6-20的芳基”的定义相似,仅是碳原子数不同而已。"C 1-10 alkyl group", "C 6-15 aryl group", "C 1-5 alkyl group", "C 6-10 aryl group" and the aforementioned "C 1-20 alkyl group" Similar to the definition of "C 6-20 aryl group", only the number of carbon atoms is different.
如前所述,本发明的第一方面提供了一种将醇进行脱氧官能化的方法,该方法包括:As previously mentioned, a first aspect of the present invention provides a method for deoxyfunctionalizing an alcohol, the method comprising:
(1)在第一溶剂中,在活化剂存在下,将醇进行脱氧活化,得到碘代物中间体;(1) in the first solvent, in the presence of an activator, the alcohol is deoxidized and activated to obtain an iodide intermediate;
(2)在第二溶剂中,在亲核试剂存在下,将所述碘代物中间体进行官能化,得到醇官能化物质;(2) in a second solvent, in the presence of a nucleophile, the iodide intermediate is functionalized to obtain an alcohol-functionalized substance;
其中,所述活化剂具有式(I)所示的结构;Wherein, the activator has the structure shown in formula (I);
其中,在式(I)中,Wherein, in formula (I),
Ra、Rb和Rc各自独立地选自取代或未取代的烷基、取代或未取代的芳基,且Ra、Rb和Rc中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R a , R b and R c are each independently selected from substituted or unsubstituted alkyl, substituted or unsubstituted aryl, and the optional substituents in R a , R b and R c are each independently selected from At least one of halogen, alkoxy, alkyl, aryl, heteroaryl, and amine.
根据本发明,所述任选存在的取代基是指取代基可以存在也可以不存在,对各个任选存在的取代基的取代位置以及取代数量没有特别的限制,可以在任意能够取代的位置进行取代。According to the present invention, the optional substituent refers to that the substituent may or may not be present. There is no particular limitation on the substitution position and substitution quantity of each optional substituent, and the substitution can be carried out at any position that can be substituted. replace.
优选地,在式(I)中,Preferably, in formula (I),
Ra、Rb和Rc各自独立地选自取代或未取代的C1-20的烷基、取代或未取代的C6-20的芳基,且Ra、Rb和Rc中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R a , R b and R c are each independently selected from substituted or unsubstituted C 1-20 alkyl groups, substituted or unsubstituted C 6-20 aryl groups, and any of R a , R b and R c The optional substituents are each independently selected from at least one of halogen, alkoxy, alkyl, aryl, heteroaryl, and amine.
更优选地,在式(I)中,More preferably, in formula (I),
Ra、Rb和Rc各自独立地选自取代或未取代的C1-10的烷基、取代或未取代的C6-15的芳基,且Ra、Rb和Rc中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R a , R b and R c are each independently selected from substituted or unsubstituted C 1-10 alkyl groups, substituted or unsubstituted C 6-15 aryl groups, and any of R a , R b and R c The optional substituents are each independently selected from at least one of halogen, alkoxy, alkyl, aryl, heteroaryl, and amine.
进一步优选地,所述活化剂选自三甲基碘硅烷、三乙基碘硅烷、三异丙基碘硅烷、三正丁基碘硅烷、三叔丁基碘硅烷、二甲基叔丁基碘硅烷、三环己基碘硅烷和三苯基碘硅烷中的至少一种。Further preferably, the activator is selected from trimethyl iodide silane, triethyl iodide silane, triisopropyl iodide silane, tri-n-butyl iodide silane, tri-tert-butyl iodide silane, dimethyl tert-butyl iodide At least one of silane, tricyclohexyliodosilane and triphenyliodosilane.
更进一步优选地,所述活化剂为三甲基碘硅烷。More preferably, the activator is trimethylsilyl iodide.
优选地,所述醇为一级和/或二级醇,所述醇具有式(II)所示的结构,所述碘代物中间体具有式(II’)所示的结构:Preferably, the alcohol is a primary and/or secondary alcohol, the alcohol has the structure shown in formula (II), and the iodide intermediate has the structure shown in formula (II'):
在式(II)和式(II’)中,In formula (II) and formula (II'),
R1和R2各自独立地选自代表氢、取代或未取代的烷基、取代或未取代的芳基,且R1和R2中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R 1 and R 2 are each independently selected from representing hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, and the optional substituents in R 1 and R 2 are each independently selected from halogen, alkane At least one of an oxy group, an alkyl group, an aryl group, a heteroaryl group, and an amine group.
优选地,在式(II)和式(II’)中,Preferably, in formula (II) and formula (II'),
R1和R2各自独立地选自代表氢、取代或未取代的C1-20的烷基和取代或未取代的C6-20的芳基,且R1和R2中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R 1 and R 2 are each independently selected from representing hydrogen, a substituted or unsubstituted C 1-20 alkyl group, and a substituted or unsubstituted C 6-20 aryl group, and R 1 and R 2 are optionally present in The substituents are each independently selected from at least one of halogen, alkoxy, alkyl, aryl, heteroaryl, and amine.
更优选地,在式(II)和式(II’)中,More preferably, in formula (II) and formula (II'),
R1和R2各自独立地选自代表氢、取代或未取代的C1-10的烷基、取代或未取代的C6-15的芳基,且R1和R2中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R 1 and R 2 are each independently selected from representing hydrogen, substituted or unsubstituted C 1-10 alkyl, substituted or unsubstituted C 6-15 aryl, and R 1 and R 2 are optionally present in The substituents are each independently selected from at least one of halogen, alkoxy, alkyl, aryl, heteroaryl, and amine.
进一步优选地,在式(II)和式(II’)中,Further preferably, in formula (II) and formula (II'),
R1和R2各自独立地选自代表氢、取代或未取代的C1-5的烷基、取代或未取代的C6-10的芳基,且R1和R2中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R 1 and R 2 are each independently selected from representing hydrogen, substituted or unsubstituted C 1-5 alkyl, substituted or unsubstituted C 6-10 aryl, and R 1 and R 2 are optionally present in The substituents are each independently selected from at least one of halogen, alkoxy, alkyl, aryl, heteroaryl, and amine.
更进一步优选地,所述醇选自以下化合物中的至少一种:Further preferably, the alcohol is selected from at least one of the following compounds:
优选地,本发明提供的方法由如下式(1)表示:Preferably, the method provided by the present invention is represented by the following formula (1):
在式(1)中,HNu和Nu-表示选自含氮亲核试剂、含硫亲核试剂、含碳亲核试剂、含卤素亲核试剂和含氧亲核试剂中的至少一种亲核试剂;Nu表示选自含氮基团、含硫基团、含碳基团、含卤素基团和含氧基团中的至少一种基团。In formula (1), HNu and Nu - represent at least one nucleophile selected from the group consisting of nitrogen-containing nucleophiles, sulfur-containing nucleophiles, carbon-containing nucleophiles, halogen-containing nucleophiles, and oxygen-containing nucleophiles Reagent; Nu represents at least one group selected from nitrogen-containing groups, sulfur-containing groups, carbon-containing groups, halogen-containing groups, and oxygen-containing groups.
优选地,在步骤(1)中,所述活化剂与醇的用量摩尔比为1-4:1。Preferably, in step (1), the molar ratio of the activator to alcohol is 1-4:1.
优选地,在步骤(1)中,所述脱氧活化的条件包括:零下20℃至零上100℃,时间为0.5-20h。Preferably, in step (1), the conditions for the deoxidation activation include: minus 20° C. to minus 100° C., and the time is 0.5-20 h.
优选地,在步骤(1)中,所述脱氧活化在保护气氛和遮光条件下进行。Preferably, in step (1), the deoxidation activation is carried out under protective atmosphere and shading conditions.
根据本发明一种优选的具体实施方式,在步骤(1)中,所述醇为手性二级醇,所述碘代物中间体为手性碘代物,且所述碘代物中间体与所述醇的光学构型相反。According to a preferred embodiment of the present invention, in step (1), the alcohol is a chiral secondary alcohol, the iodide intermediate is a chiral iodide, and the iodide intermediate is the same as the The optical configuration of alcohols is reversed.
根据本发明,两种物质的光学构型相反表示二者的光学构型互为翻转,例如当所述醇的光学构型为R型,则所述碘代物中间体的光学构型为S型。According to the present invention, the opposite optical configurations of the two substances means that the optical configurations of the two substances are reversed. For example, when the optical configuration of the alcohol is R type, the optical configuration of the iodide intermediate is S type. .
优选地,在步骤(1)中,所述第一溶剂选自二氯甲烷、二氯乙烷、氯仿、二氧六环和乙腈中的至少一种,更优选为二氯甲烷。Preferably, in step (1), the first solvent is selected from at least one of dichloromethane, dichloroethane, chloroform, dioxane and acetonitrile, more preferably dichloromethane.
本发明对所述第一溶剂的用量没有特别限制,本领域技术人员可以根据需求进行合理选择。The present invention does not specifically limit the amount of the first solvent, and those skilled in the art can make a reasonable selection according to requirements.
根据本发明,步骤(1)还包括将脱氧活化后的溶液脱溶,得到所述碘代物中间体。本发明对所述脱溶的具体操作没有特别限制,可以采用本领域现有的脱溶除溶剂的方法进行,只要能够得到所述碘代物中间体即可。According to the present invention, step (1) further comprises desolvating the deoxidized activated solution to obtain the iodide intermediate. The present invention has no particular limitation on the specific operation of the precipitation, which can be carried out by using the existing methods of precipitation and solvent removal in the art, as long as the iodide intermediate can be obtained.
根据本发明,得到所述碘代物中间体无需进行进一步纯化即可进行步骤(2)的反应,操作简单。According to the present invention, the reaction of step (2) can be carried out without further purification to obtain the iodide intermediate, and the operation is simple.
根据本发明,在步骤(1)中,除所述碘代物中间体,虽然还可能会产生硅醇(如三甲基硅醇)和硅醚(如六甲基硅醚)的副产物,但所述硅醇和硅醚副产物均能通过蒸馏方法回收利用。According to the present invention, in step (1), in addition to the iodide intermediate, although by-products of silanol (such as trimethylsilanol) and silyl ether (such as hexamethylsilyl ether) may also be produced, Both the silanol and silyl ether by-products can be recycled by distillation.
根据本发明,所述醇进行脱氧官能化是指将所述醇进行包括脱氧胺化、脱氧硫化、脱氧酯化、脱氧醚化、脱氧卤化、脱氧碳化、脱氧酰胺化、脱氧磺酰胺化等。According to the present invention, deoxyfunctionalization of the alcohol refers to deoxyamination, deoxysulfurization, deoxyesterification, deoxyetherification, deoxyhalogenation, deoxycarbonation, deoxyamidation, deoxysulfonamidation, etc. of the alcohol.
优选地,在步骤(2)中,所述官能化选自胺化、硫化、碳化、卤化、酰胺化、磺酰胺化、酯化和醚化中的至少一种。Preferably, in step (2), the functionalization is selected from at least one of amination, sulfurization, carbonization, halogenation, amidation, sulfonamidation, esterification and etherification.
更优选地,在步骤(2)中,所述官能化选自胺化、硫化、磺酰胺化、酯化和醚化中的至少一种。More preferably, in step (2), the functionalization is selected from at least one of amination, sulfurization, sulfonamidation, esterification and etherification.
优选地,在步骤(2)中,所述亲核试剂选自含氮亲核试剂、含硫亲核试剂、含碳亲核试剂、含卤素亲核试剂和含氧亲核试剂中的至少一种。Preferably, in step (2), the nucleophile is selected from at least one of nitrogen-containing nucleophiles, sulfur-containing nucleophiles, carbon-containing nucleophiles, halogen-containing nucleophiles and oxygen-containing nucleophiles kind.
以下对所述含氮亲核试剂的优选的具体实施方式进行展开说明。Preferred specific embodiments of the nitrogen-containing nucleophile will be described below.
根据本发明一种优选的具体实施方式,所述含氮亲核试剂选自叠氮盐、酰胺、磺酰胺、一级脂肪胺、二级脂肪胺、一级芳香胺、二级芳香胺和氮杂芳环中的至少一种。According to a preferred embodiment of the present invention, the nitrogen-containing nucleophile is selected from the group consisting of azide salts, amides, sulfonamides, primary aliphatic amines, secondary aliphatic amines, primary aromatic amines, secondary aromatic amines and nitrogen at least one of the heteroaromatic rings.
根据本发明,优选地,所述叠氮盐选自NaN3、TMSN3中的至少一种。According to the present invention, preferably, the azide salt is selected from at least one of NaN 3 and TMSN 3 .
根据本发明,优选地,所述酰胺选自甲酰胺、乙酰胺、丙酰胺,丁二酰亚胺,邻苯丁二酰亚胺中的至少一种。According to the present invention, preferably, the amide is selected from at least one of formamide, acetamide, propionamide, succinimide, and phthalimide.
根据本发明,优选地,所述磺酰胺选自甲磺酰胺、苯磺酰胺、对甲苯磺酰胺、二对甲苯磺酰亚胺和中的至少一种:According to the present invention, preferably, the sulfonamide is selected from methanesulfonamide, benzenesulfonamide, p-toluenesulfonamide, di-p-toluenesulfonimide and At least one of:
根据本发明,优选地,所述一级脂肪胺选自正丙胺、正丁胺、正戊胺、正己胺、苄胺、2-苯基乙胺、3-苯基丙胺、4-苯基丁胺中的至少一种。According to the present invention, preferably, the primary aliphatic amine is selected from n-propylamine, n-butylamine, n-pentylamine, n-hexylamine, benzylamine, 2-phenylethylamine, 3-phenylpropylamine, 4-phenylbutylamine at least one of amines.
根据本发明,所述二级脂肪胺包括二级非环或环状的脂肪胺,优选地,所述二级脂肪胺选自以下化合物中的中的至少一种:According to the present invention, the secondary aliphatic amine includes secondary acyclic or cyclic aliphatic amine, preferably, the secondary aliphatic amine is selected from at least one of the following compounds:
根据本发明,优选地,所述一级芳香胺选自苯胺、邻甲苯胺、间甲苯胺、对甲苯胺、邻氯苯胺、间氯苯胺、对氯苯胺、α-萘胺,β-萘胺中的至少一种。According to the present invention, preferably, the primary aromatic amine is selected from aniline, o-toluidine, m-toluidine, p-toluidine, o-chloroaniline, m-chloroaniline, p-chloroaniline, α-naphthylamine, β-naphthylamine at least one of them.
根据本发明,优选地,所述二级芳香胺选自N-甲基苯胺,N-甲基苄胺、N-乙基苯胺,二苯胺、二氢吲哚、四氢喹啉中的至少一种。According to the present invention, preferably, the secondary aromatic amine is selected from at least one of N-methylaniline, N-methylbenzylamine, N-ethylaniline, diphenylamine, indoline, and tetrahydroquinoline kind.
根据本发明,优选地,所述氮杂芳环选自吡唑、咪唑、噁唑、噻唑、三氮唑、苯并吡唑、苯并咪唑、苯并噁唑、苯并噻唑、苯并三氮唑中的至少一种。According to the present invention, preferably, the aza aromatic ring is selected from pyrazole, imidazole, oxazole, thiazole, triazole, benzopyrazole, benzimidazole, benzoxazole, benzothiazole, benzotriazole at least one of azoles.
更优选地,所述含氮亲核试剂选自以下化合物中的至少一种:More preferably, the nitrogen-containing nucleophile is selected from at least one of the following compounds:
NaN3、 NaN 3 ,
以下对所述含硫亲核试剂的优选的具体实施方式进行展开说明。Preferred specific embodiments of the sulfur-containing nucleophile will be described below.
根据本发明一种优选的具体实施方式,所述含硫亲核试剂选自脂肪硫醇、取代或未取代的苯硫酚盐、取代或未取代的苯硫酚、杂芳硫醇和苯基亚磺酸钠中的至少一种,且所述含硫亲核试剂中任选存在的取代基各自独立地选自卤素、烷基、烷氧基、芳基、胺基中的至少一种。According to a preferred embodiment of the present invention, the sulfur-containing nucleophile is selected from aliphatic thiols, substituted or unsubstituted thiophenates, substituted or unsubstituted thiophenols, heteroarylthiols and phenylenes At least one of sodium sulfonate, and the optional substituents in the sulfur-containing nucleophile are each independently selected from at least one of halogen, alkyl, alkoxy, aryl, and amine.
根据本发明,优选地,所述脂肪硫醇选自乙硫醇、丙硫醇、正丁硫醇、苄基硫醇、苯乙硫醇、苯丙硫醇中的至少一种。According to the present invention, preferably, the fatty thiol is selected from at least one of ethanethiol, propanethiol, n-butanethiol, benzylthiol, phenylethanethiol, and phenylpropanethiol.
根据本发明,优选地,所述取代或未取代的苯硫酚盐选自苯硫酚钠、苯硫酚钾、苯硫酚锂、4-甲基苯硫酚钠中的至少一种。According to the present invention, preferably, the substituted or unsubstituted thiophenate is selected from at least one of sodium thiophenate, potassium thiophenate, lithium thiophenate, and sodium 4-methylthiophenate.
根据本发明,优选地,取代或未取代的苯硫酚选自以下化合物中的至少一种:According to the present invention, preferably, the substituted or unsubstituted thiophenol is selected from at least one of the following compounds:
根据本发明,优选地,所述杂芳硫醇选自以下化合物中的至少一种:According to the present invention, preferably, the heteroaryl thiol is selected from at least one of the following compounds:
更优选地,所述含硫亲核试剂选自以下化合物中的至少一种:More preferably, the sulfur-containing nucleophile is selected from at least one of the following compounds:
以下对所述含氧亲核试剂的优选的具体实施方式进行展开说明。Preferred specific embodiments of the oxygen-containing nucleophile will be described below.
优选地,所述含氧亲核试剂选自脂肪羧酸盐、取代或未取代的芳香羧酸盐、取代或未取代的烷基醇、取代或未取代的烷基醇盐、取代或未取代的苯酚盐、取代或未取代的苯酚中的至少一种,且所述所述含氧亲核试剂中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、胺基中的至少一种。Preferably, the oxygen-containing nucleophile is selected from aliphatic carboxylates, substituted or unsubstituted aromatic carboxylates, substituted or unsubstituted alkyl alcohols, substituted or unsubstituted alkyl alcohol salts, substituted or unsubstituted alkyl alcohols At least one of phenolate, substituted or unsubstituted phenol, and the optional substituents in the oxygen-containing nucleophile are each independently selected from halogen, alkoxy, alkyl, aryl, at least one of the amine groups.
根据本发明,优选地,所述脂肪羧酸盐选自甲酸钠、乙酸钠、乙酸钾、丙酸钠、苯乙酸钠、硬脂酸钠中的至少一种。According to the present invention, preferably, the fatty carboxylate is selected from at least one of sodium formate, sodium acetate, potassium acetate, sodium propionate, sodium phenylacetate, and sodium stearate.
根据本发明,优选地,所述取代或未取代的芳香羧酸盐选自苯甲酸钠、3,5-二氟苯甲酸钠中的至少一种。According to the present invention, preferably, the substituted or unsubstituted aromatic carboxylate is selected from at least one of sodium benzoate and sodium 3,5-difluorobenzoate.
根据本发明,优选地,所述取代或未取代的烷基醇选自甲醇、乙醇、丙醇、异丙醇、丁醇、苄醇、烯丙醇、丙炔醇、氯乙醇、溴乙醇、三氟乙醇、乙二醇单甲醚、乙二醇单乙醚中的至少一种。According to the present invention, preferably, the substituted or unsubstituted alkyl alcohol is selected from methanol, ethanol, propanol, isopropanol, butanol, benzyl alcohol, allyl alcohol, propargyl alcohol, chloroethanol, bromoethanol, At least one of trifluoroethanol, ethylene glycol monomethyl ether, and ethylene glycol monoethyl ether.
根据本发明,优选地,所述取代或未取代的烷基醇盐选自甲醇钠、乙醇钠、丙醇钠中的至少一种。According to the present invention, preferably, the substituted or unsubstituted alkyl alkoxide is selected from at least one of sodium methoxide, sodium ethoxide, and sodium propoxide.
根据本发明,优选地,所述取代或未取代的苯酚盐选自苯酚钠、邻硝基苯酚钠、对硝基苯酚钠中的至少一种。According to the present invention, preferably, the substituted or unsubstituted phenate is selected from at least one of sodium phenate, sodium o-nitrophenolate, and sodium p-nitrophenolate.
根据本发明,优选地,所述取代或未取代的苯酚选自苯酚、邻甲苯酚、间甲苯酚、对甲苯酚、邻氯苯酚、间氯苯酚、对氯苯酚、邻甲氧基苯酚、间甲氧基苯酚、对甲氧基苯酚中的至少一种。According to the present invention, preferably, the substituted or unsubstituted phenol is selected from phenol, o-cresol, m-cresol, p-cresol, o-chlorophenol, m-chlorophenol, p-chlorophenol, o-methoxyphenol, m- At least one of methoxyphenol and p-methoxyphenol.
更优选地,所述含氧亲核试剂选自以下化合物中的至少一种:More preferably, the oxygen-containing nucleophile is selected from at least one of the following compounds:
优选地,所述含卤素亲核试剂选自氟化钠、氟化钾、氟氢化钾、氯化钠、氯化钾、溴化钠、溴化钾、碘化钠、碘化钾中的至少一种。Preferably, the halogen-containing nucleophile is selected from at least one of sodium fluoride, potassium fluoride, potassium hydrogen fluoride, sodium chloride, potassium chloride, sodium bromide, potassium bromide, sodium iodide, potassium iodide .
优选地,所述含碳亲核试剂选自乙酰乙酸乙酯、丙二腈、丙酸二乙酯、氰基乙酸乙酯、2,4-戊二酮中的至少一种。Preferably, the carbon-containing nucleophile is selected from at least one of ethyl acetoacetate, malononitrile, diethyl propionate, ethyl cyanoacetate, and 2,4-pentanedione.
更优选地,所述亲核试剂选自含氮亲核试剂、含硫亲核试剂和含氧亲核试剂中的至少一种。More preferably, the nucleophile is selected from at least one of nitrogen-containing nucleophiles, sulfur-containing nucleophiles and oxygen-containing nucleophiles.
根据本发明,优选地,在步骤(2)中,所述亲核试剂与所述醇的用量摩尔比为1-4:1。According to the present invention, preferably, in step (2), the molar ratio of the amount of the nucleophile to the alcohol is 1-4:1.
根据本发明,优选地,在步骤(2)中,所述官能化的条件包括:温度为零下20℃至零上160℃,时间为0.5-20h。According to the present invention, preferably, in step (2), the functionalization conditions include: a temperature of minus 20° C. to plus a zero of 160° C., and a time of 0.5-20 h.
优选地,所述官能化反应在保护气氛中进行。根据本发明,所述保护气氛由选自氮气和惰性气氛中的至少一种物质提供。Preferably, the functionalization reaction is carried out in a protective atmosphere. According to the present invention, the protective atmosphere is provided by at least one substance selected from nitrogen and an inert atmosphere.
优选地,步骤(2)在碱性物质存在下进行。Preferably, step (2) is carried out in the presence of an alkaline substance.
优选地,所述碱性物质选自碳酸钾、碳酸钠、碳酸铯、碳酸氢钠、碳酸氢钾、氢氧化钠、氢氧化钾中的至少一种。Preferably, the alkaline substance is selected from at least one of potassium carbonate, sodium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, and potassium hydroxide.
优选地,相对于1mmol的亲核试剂,所述碱性物质的用量为0.5-2mmol。Preferably, the amount of the basic substance is 0.5-2 mmol relative to 1 mmol of the nucleophile.
优选地,步骤(2)在催化剂存在下进行。Preferably, step (2) is carried out in the presence of a catalyst.
优选地,所述催化剂为Ag2O。Preferably, the catalyst is Ag 2 O.
优选地,相对于1mmol的亲核试剂,所述催化剂的用量为1-5mmol。Preferably, the amount of the catalyst is 1-5 mmol relative to 1 mmol of the nucleophile.
优选地,在步骤(2)中,所述第二溶剂选自乙腈、N,N-二甲基甲酰胺(DMF)、二甲亚砜、二氯甲烷、三氯甲烷、二氯乙烷、二氧六环中的至少一种。更优选为乙腈或N,N-二甲基甲酰胺。Preferably, in step (2), the second solvent is selected from acetonitrile, N,N-dimethylformamide (DMF), dimethyl sulfoxide, dichloromethane, chloroform, dichloroethane, at least one of dioxane. More preferably, it is acetonitrile or N,N-dimethylformamide.
优选地,在步骤(2)中,相对于1mmol的所述醇,所述第二溶剂的用量为2-20mL。Preferably, in step (2), the amount of the second solvent is 2-20 mL relative to 1 mmol of the alcohol.
根据本发明所述的方法,以下提供几种优选的具体实施方式。According to the method of the present invention, several preferred specific embodiments are provided below.
具体实施方式1Embodiment 1
所述官能化为胺化,所述亲核试剂为含氮亲核试剂,该方法包括:The functionalization is amination, the nucleophile is a nitrogen-containing nucleophile, and the method comprises:
(1)在第一溶剂中,在活化剂存在下,将醇进行脱氧活化,得到碘代物中间体;(1) in the first solvent, in the presence of an activator, the alcohol is deoxidized and activated to obtain an iodide intermediate;
(2)在第二溶剂中,在含氮亲核试剂存在下,将所述碘代物中间体进行官能化。(2) Functionalizing the iodide intermediate in a second solvent in the presence of a nitrogen-containing nucleophile.
优选地,所述活化剂为三甲基碘硅烷。Preferably, the activator is trimethyliodosilane.
优选地,所述含氮亲核试剂选自叠氮盐、酰胺、磺酰胺、一级脂肪胺、二级非环或环状脂肪胺、一级芳香胺、二级芳香胺和氮杂芳环中的至少一种。Preferably, the nitrogen-containing nucleophile is selected from the group consisting of azide salts, amides, sulfonamides, primary aliphatic amines, secondary acyclic or cyclic aliphatic amines, primary aromatic amines, secondary aromatic amines and aza aromatic rings at least one of them.
优选地,所述胺化官能化由如下式(2)表示:Preferably, the amination functionalization is represented by the following formula (2):
其中,式(2)中,R1和R2与前述R1和R2定义对应相同;Wherein, in formula (2), R 1 and R 2 are the same as the definitions of the aforementioned R 1 and R 2 ;
R3和R4各自独立地选自氢、取代或未取代的烷基、取代或未取代的苯基、酰基、磺酰基中的至少一种,或者R3、R4和N原子环合形成环状脂肪胺或者R3、R4和N原子环合形成氮杂芳环,所述任选存在的取代基选自卤素、烷基、烷氧基、芳基、胺基中的至少一种。R 3 and R 4 are each independently selected from at least one of hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted phenyl, acyl, and sulfonyl, or R 3 , R 4 and N atoms are cyclized to form Cyclic aliphatic amines or R 3 , R 4 and N atoms are cyclized to form nitrogen heteroaromatic rings, and the optional substituents are selected from at least one of halogen, alkyl, alkoxy, aryl, and amine groups .
根据本发明一种优选的具体实施方式:According to a preferred embodiment of the present invention:
所述含氮亲核试剂为叠氮盐;所述第二溶剂为DMF,所述官能化的条件包括:温度为20-60℃,时间为2-16h。The nitrogen-containing nucleophile is an azide salt; the second solvent is DMF, and the functionalization conditions include: a temperature of 20-60° C. and a time of 2-16 hours.
根据本发明另一种优选的具体实施方式:According to another preferred embodiment of the present invention:
所述含氮亲核试剂选自一级脂肪胺、二级(非环或环状)脂肪胺、一级芳香胺、二级芳香胺和氮杂芳环中的至少一种;所述第二溶剂为乙腈,所述官能化的条件包括:在加热回流状态下进行,温度为20-100℃,时间为0.5-20h。The nitrogen-containing nucleophile is selected from at least one of primary aliphatic amines, secondary (acyclic or cyclic) aliphatic amines, primary aromatic amines, secondary aromatic amines and nitrogen heteroaromatic rings; the second The solvent is acetonitrile, and the functionalization conditions include: heating under reflux, the temperature is 20-100°C, and the time is 0.5-20h.
根据本发明再一种优选的具体实施方式:According to another preferred embodiment of the present invention:
所述碘代物中间体为手性碘代物,且所述含氮亲核试剂为叠氮盐,所述胺化反应产物为手性叠氮化产物,且所述手性叠氮化产物与所述碘代物中间体的光学构型相反,也即,所述醇为手性醇、含氮亲核试剂为叠氮盐时,所述胺化反应产物的光学构型保持醇(手性醇)的光学构型。The iodide intermediate is a chiral iodide, the nitrogen-containing nucleophile is an azide salt, the amination reaction product is a chiral azide product, and the chiral azide product is the same as the chiral azide product. The optical configuration of the iodide intermediate is opposite, that is, when the alcohol is a chiral alcohol and the nitrogen-containing nucleophile is an azide salt, the optical configuration of the amination reaction product maintains the alcohol (chiral alcohol) optical configuration.
具体实施方式2Embodiment 2
所述官能化为硫化,所述亲核试剂为含硫亲核试剂,该方法包括:The functionalization is sulfurization, the nucleophile is a sulfur-containing nucleophile, and the method includes:
(1)在第一溶剂中,在活化剂存在下,将醇进行脱氧活化,得到碘代物中间体;(1) in the first solvent, in the presence of an activator, the alcohol is deoxidized and activated to obtain an iodide intermediate;
(2)在第二溶剂中,在含硫亲核试剂存在下,将所述碘代物中间体进行官能化。(2) Functionalizing the iodide intermediate in a second solvent in the presence of a sulfur-containing nucleophile.
优选地,所述活化剂为三甲基碘硅烷。Preferably, the activator is trimethyliodosilane.
优选地,所述含硫亲核试剂选自脂肪硫醇、取代或未取代的苯硫酚盐、取代或未取代的苯硫酚、杂芳硫醇和苯基亚磺酸钠中的至少一种,所述任选存在的取代基选自卤素、烷基、烷氧基、芳基、胺基中的至少一种。Preferably, the sulfur-containing nucleophile is selected from at least one of aliphatic thiol, substituted or unsubstituted thiophenate, substituted or unsubstituted thiophenol, heteroarylthiol and sodium phenylsulfinate , the optional substituent is selected from at least one of halogen, alkyl, alkoxy, aryl, and amine.
优选地,所述硫化官能化反应由如下式(3)表示:Preferably, the sulfur functionalization reaction is represented by the following formula (3):
其中,式(3)中,R1和R2与前述R1和R2定义对应相同;Wherein, in formula (3), R 1 and R 2 are the same as the definitions of the aforementioned R 1 and R 2 ;
R5选自烷基、取代或未取代的苯基、杂芳基,所述任选存在的取代基选自卤素、烷基、烷氧基、芳基、胺基中的至少一种。R 5 is selected from alkyl, substituted or unsubstituted phenyl, and heteroaryl, and the optional substituent is selected from at least one of halogen, alkyl, alkoxy, aryl, and amine.
根据本发明一种优选的具体实施方式:According to a preferred embodiment of the present invention:
所述含硫亲核试剂为取代或未取代的苯硫酚盐和/或苯基亚磺酸钠,步骤(2)包括:The sulfur-containing nucleophile is substituted or unsubstituted thiophenate and/or sodium phenylsulfinate, and step (2) includes:
在第二溶剂中,在含硫亲核试剂存在下,将所述碘代物中间体进行硫化。The iodide intermediate is sulfurized in the second solvent in the presence of a sulfur-containing nucleophile.
优选地,所述硫化的条件包括:温度为0-45℃,时间为0.5-8h。Preferably, the vulcanization conditions include: a temperature of 0-45° C. and a time of 0.5-8 h.
根据本发明另一种优选的具体实施方式:According to another preferred embodiment of the present invention:
所述含硫亲核试剂为脂肪硫醇、取代或未取代苯硫酚或杂芳硫醇,步骤(2)包括:The sulfur-containing nucleophile is aliphatic thiol, substituted or unsubstituted thiophenol or heteroaromatic thiol, and step (2) includes:
在第二溶剂中,在含硫亲核试剂和碱性物质存在下,将所述碘代物中间体进行硫化。The iodide intermediate is sulfurized in a second solvent in the presence of a sulfur-containing nucleophile and a basic species.
优选地,相对于1mmol的亲核试剂,所述碱性物质的用量为0.5-2mmol。Preferably, the amount of the basic substance is 0.5-2 mmol relative to 1 mmol of the nucleophile.
优选地,所述硫化的条件包括:温度为0-45℃,时间为0.5-8h。Preferably, the vulcanization conditions include: a temperature of 0-45° C. and a time of 0.5-8 h.
根据本发明又一种优选的具体实施方式:According to another preferred embodiment of the present invention:
所述碘代物中间体为手性碘代物,且所述含硫亲核试剂为取代或未取代的苯硫酚,所述硫化反应产物为手性硫化产物,所述手性硫化产物与所述碘代物中间体的光学构型相反。也即,所述醇为手性醇、含硫亲核试剂为取代苯硫酚时,所述硫化反应产物的光学构型保持醇(手性醇)的光学构型。The iodide intermediate is a chiral iodide, the sulfur-containing nucleophile is a substituted or unsubstituted thiophenol, the sulfide reaction product is a chiral sulfide product, and the chiral sulfide product is the same as the chiral sulfide product. The optical configuration of the iodide intermediate is reversed. That is, when the alcohol is a chiral alcohol and the sulfur-containing nucleophile is a substituted thiophenol, the optical configuration of the sulfurization reaction product maintains the optical configuration of the alcohol (chiral alcohol).
具体实施方式3Embodiment 3
所述官能化为酯化和/或醚化,所述亲核试剂为含氧亲核试剂,该方法包括:The functionalization is esterification and/or etherification, the nucleophile is an oxygen-containing nucleophile, and the method comprises:
(1)在第一溶剂中,在活化剂存在下,将醇进行脱氧活化,得到碘代物中间体;(1) in the first solvent, in the presence of an activator, the alcohol is deoxidized and activated to obtain an iodide intermediate;
(2)在第二溶剂中,在含氧亲核试剂存在下,将所述碘代物中间体进行官能化。(2) Functionalizing the iodide intermediate in a second solvent in the presence of an oxygen-containing nucleophile.
优选地,所述活化剂为三甲基碘硅烷。Preferably, the activator is trimethyliodosilane.
优选地,所述含氧亲核试剂选自脂肪羧酸盐、取代或未取代的芳香羧酸盐、取代或未取代的烷基醇、取代或未取代的烷基醇盐、取代或未取代的苯酚盐、取代或未取代的苯酚中的至少一种,所述任选存在的取代基选自卤素、烷氧基、烷基、芳基、胺基中的至少一种。Preferably, the oxygen-containing nucleophile is selected from aliphatic carboxylates, substituted or unsubstituted aromatic carboxylates, substituted or unsubstituted alkyl alcohols, substituted or unsubstituted alkyl alcohol salts, substituted or unsubstituted alkyl alcohols At least one of phenolate, substituted or unsubstituted phenol, and the optional substituent is selected from at least one of halogen, alkoxy, alkyl, aryl, and amine.
优选地,所述氧化官能化由如下式(4)表示:Preferably, the oxidative functionalization is represented by the following formula (4):
其中,式(4)中,R1和R2与前述R1和R2定义对应相同;Wherein, in formula (4), R 1 and R 2 are the same as the definitions of the aforementioned R 1 and R 2 ;
R6选自取代或未取代的烷基、脂肪酰基、取代或未取代的苯甲酰基、取代或未取代的苯基,所述任选存在的取代基选自卤素、烷氧基、烷基、芳基、胺基中的至少一种。R 6 is selected from substituted or unsubstituted alkyl, fatty acyl, substituted or unsubstituted benzoyl, substituted or unsubstituted phenyl, and the optional substituent is selected from halogen, alkoxy, alkyl , at least one of aryl and amine groups.
根据本发明一种优选的具体实施方式:According to a preferred embodiment of the present invention:
所述含氧亲核试剂为脂肪羧酸盐和/或取代或未取代的芳香羧酸盐,所述第二溶剂为DMF,步骤(2)包括:The oxygen-containing nucleophile is aliphatic carboxylates and/or substituted or unsubstituted aromatic carboxylates, the second solvent is DMF, and step (2) includes:
在第二溶剂中,在含氧亲核试剂存在下,将所述碘代物中间体进行官能化。The iodide intermediate is functionalized in the second solvent in the presence of an oxygen-containing nucleophile.
根据本发明又一种优选的具体实施方式:According to another preferred embodiment of the present invention:
所述含氧亲核试剂为取代或未取代的苯酚,所述第二溶剂为乙腈,步骤(2)包括:The oxygen-containing nucleophile is substituted or unsubstituted phenol, the second solvent is acetonitrile, and step (2) includes:
在第二溶剂中,在含氧亲核试剂和碱性物质存在下,将所述碘代物中间体进行官能化。The iodide intermediate is functionalized in the second solvent in the presence of an oxygen-containing nucleophile and a basic species.
优选地,所述碱性物质为碳酸钠。Preferably, the alkaline substance is sodium carbonate.
优选地,相对于1mmol的亲核试剂,所述碱性物质的用量为0.5-2mmol。Preferably, the amount of the basic substance used is 0.5-2 mmol relative to 1 mmol of the nucleophile.
根据本发明又一种优选的具体实施方式:According to another preferred embodiment of the present invention:
所述含氧亲核试剂为苄醇,所述第二溶剂为乙腈,步骤(2)包括:The oxygen-containing nucleophile is benzyl alcohol, the second solvent is acetonitrile, and step (2) includes:
在第二溶剂中,在含氧亲核试剂和催化剂存在下,将所述碘代物中间体进行官能化反应,所述官能化反应为醚化反应。In the second solvent, in the presence of an oxygen-containing nucleophile and a catalyst, the iodide intermediate is subjected to a functionalization reaction, which is an etherification reaction.
优选地,所述催化剂为Ag2O。Preferably, the catalyst is Ag 2 O.
优选地,相对于1mmol的亲核试剂,所述催化剂的用量为1-5mmol。Preferably, the amount of the catalyst is 1-5 mmol relative to 1 mmol of the nucleophile.
根据本发明所述的方法,本发明的方法中还包括将官能化反应后的反应液依次进行萃取、干燥和分离纯化,得到醇官能化物质。通过本发明的方法能够实现经简单的后处理操作即可分离纯化得到官能化物质。According to the method of the present invention, the method of the present invention further comprises sequentially extracting, drying, and separating and purifying the reaction solution after the functionalization reaction to obtain an alcohol-functionalized substance. The method of the present invention can realize that the functionalized substance can be separated and purified by simple post-processing operation.
优选地,所述萃取的条件包括:先用水稀释,再用二氯甲烷萃取,有机液再用饱和食盐水进行洗涤。Preferably, the extraction conditions include: first diluting with water, then extracting with dichloromethane, and washing the organic liquid with saturated brine.
优选地,所述干燥的条件包括:采用干燥剂进行干燥,所述干燥剂例如为Na2SO4。Preferably, the drying conditions include: drying with a desiccant, such as Na 2 SO 4 .
优选地,所述分离纯化采用柱色谱方法进行,所述柱色谱的条件包括:使用100-200目硅胶,洗脱剂为石油醚和乙酸乙酯。Preferably, the separation and purification is carried out by column chromatography, and the conditions of the column chromatography include: using 100-200 mesh silica gel, and the eluents are petroleum ether and ethyl acetate.
根据本发明,在步骤(2)中,会产生含碘盐副产物,所述含碘盐产物能通过水洗除去,或通过水层蒸发结晶方法回收利用。According to the present invention, in step (2), an iodized salt-containing by-product will be produced, and the iodized salt-containing product can be removed by washing with water, or recycled by a water-layer evaporation crystallization method.
另外,本发明中还可以包括本领域常规的其它后处理操作手段,本发明对此没有特别限制,可以采用本领域现有的操作进行,本领域技术人员不应理解为对本发明的限制。In addition, the present invention may also include other conventional post-processing operation means in the art, which is not particularly limited in the present invention, and can be performed by using existing operations in the art, which should not be construed as a limitation of the present invention by those skilled in the art.
相比于经典的Appel反应和Mitsunobu反应,本发明提供了一种操作简便、易于纯化处理的醇脱氧官能化方法,产物收率高,副产物少,产生的副产物(如硅醚、含碘盐)均能够通过蒸馏或水洗除去并回收利用,无酸废弃物生成,对环境无有害影响。Compared with the classical Appel reaction and the Mitsunobu reaction, the present invention provides an alcohol deoxyfunctionalization method that is easy to operate and easy to purify, has high product yield, few by-products, and produces by-products (such as silicon ethers, iodine-containing products, etc.). salt) can be removed by distillation or washing and recycled, no acid waste is generated, and no harmful impact on the environment.
并且,本发明的方法底物适用范围更广,亲核试剂可选种类多,与部分亲核试剂反应能够保持原料醇的光学构型。In addition, the method of the present invention has a wider range of substrates, a wide variety of nucleophiles can be selected, and the reaction with some nucleophiles can maintain the optical configuration of the raw alcohol.
如前所述,本发明的第二方面提供一种醇官能化物质,该物质选自以下化合物中的至少一种: As previously mentioned, a second aspect of the present invention provides an alcohol-functionalized substance selected from at least one of the following compounds:
如前所述,本发明的第三方面提供一种将醇进行脱氧活化的方法,该方法包括:As mentioned above, a third aspect of the present invention provides a method for deoxidizing and activating an alcohol, the method comprising:
在第一溶剂中,在活化剂存在下,将醇进行脱氧活化,所述活化剂具有式(I)所示的结构;In the first solvent, in the presence of an activator, the alcohol is deoxidized and activated, and the activator has the structure shown in formula (I);
其中,在式(I)中,Wherein, in formula (I),
Ra、Rb和Rc各自独立地选自取代或未取代的烷基、取代或未取代的芳基,且Ra、Rb和Rc中任选存在的取代基各自独立地选自卤素、烷氧基、烷基、芳基、杂芳基、胺基中的至少一种。R a , R b and R c are each independently selected from substituted or unsubstituted alkyl, substituted or unsubstituted aryl, and the optional substituents in R a , R b and R c are each independently selected from At least one of halogen, alkoxy, alkyl, aryl, heteroaryl, and amine.
根据本发明第三方面所述的方法,Ra、Rb、Rc的优选的具体实施方式与前述第一方面的定义对应相同,在此不再赘述。According to the method described in the third aspect of the present invention, the preferred specific implementations of R a , R b , and R c are the same as the definitions in the foregoing first aspect, and are not repeated here.
根据本发明第三方面所述的方法,所述活化剂选自三甲基碘硅烷、三乙基碘硅烷、三异丙基碘硅烷、三正丁基碘硅烷、三叔丁基碘硅烷、二甲基叔丁基碘硅烷、三环己基碘硅烷和三苯基碘硅烷中的至少一种,更优选为三甲基碘硅烷。According to the method of the third aspect of the present invention, the activator is selected from trimethyliodosilane, triethyliodosilane, triisopropyliodosilane, tri-n-butyliodosilane, tri-tert-butyliodosilane, At least one of dimethyl tert-butyliodosilane, tricyclohexyliodosilane and triphenyliodosilane, more preferably trimethyliodosilane.
根据本发明第三方面所述的方法,所述第一溶剂选自二氯甲烷、二氯乙烷、氯仿、二氧六环和乙腈中的至少一种,更优选为二氯甲烷。According to the method of the third aspect of the present invention, the first solvent is selected from at least one of dichloromethane, dichloroethane, chloroform, dioxane and acetonitrile, more preferably dichloromethane.
根据本发明第三方面所述的方法,所述脱氧活化的条件包括:温度为零下20℃至零上100℃,时间为0.5-20h。According to the method of the third aspect of the present invention, the conditions for the deoxidation activation include: a temperature of minus 20° C. to plus a zero of 100° C., and a time of 0.5-20 h.
根据本发明第三方面所述的方法,所述活化剂与所述醇的用量摩尔比为1-4:1。According to the method of the third aspect of the present invention, the molar ratio of the activator to the alcohol is 1-4:1.
根据本发明一种优选的具体实施方式,所述醇为无手性醇,经脱氧活化得到的所述碘代物中间体为无手性碘代物。According to a preferred embodiment of the present invention, the alcohol is an achiral alcohol, and the iodide intermediate obtained by deoxygenation activation is an achiral iodide.
根据本发明另一种优选的具体实施方式,所述醇为消旋醇,经脱氧活化得到的所述碘代物中间体为消旋碘代物。According to another preferred embodiment of the present invention, the alcohol is a racemic alcohol, and the iodide intermediate obtained by deoxygenation activation is a racemic iodide.
根据本发明又一种优选的具体实施方式,所述醇为手性醇,经脱氧活化得到的所述碘代物中间体为手性碘代物,且所述碘代物与所述醇的光学构型相反。According to another preferred embodiment of the present invention, the alcohol is a chiral alcohol, the iodide intermediate obtained by deoxygenation is a chiral iodide, and the optical configuration of the iodide and the alcohol on the contrary.
在本发明第三方面中,所述醇的优选情况与前述第一方面对应相同,为避免赘述,本发明在此不再详述。In the third aspect of the present invention, the preferred situation of the alcohol is the same as that in the first aspect. To avoid redundant description, the present invention will not describe it in detail here.
采用本发明第三方面的方法,能够对醇进行活化,得到碘代物中间体,可用于后续进一步处理,例如官能化(胺化、硫化、酯化和醚化)。与现有的对醇类物质进行活化的方法相比,本发明提供的方法产物收率高,产生的副产物(如硅醚)均能够通过蒸馏除去或回收利用,不影响后续官能化反应。Using the method of the third aspect of the present invention, the alcohol can be activated to give an iodide intermediate, which can be used for subsequent further processing, such as functionalization (amination, sulfurization, esterification and etherification). Compared with the existing method for activating alcohol substances, the method provided by the present invention has a high product yield, and the generated by-products (such as silyl ether) can be removed or recycled by distillation, without affecting the subsequent functionalization reaction.
以下将通过实例对本发明进行详细描述。The present invention will be described in detail below by way of examples.
以下实例中,在没有特别说明的情况下,所用原料均为市售品。In the following examples, the raw materials used are all commercially available products unless otherwise specified.
以下实例中,涉及到的化合物的具体结构见表1,但该方法所合成的化合物不限于表1的化合物。In the following examples, the specific structures of the involved compounds are shown in Table 1, but the compounds synthesized by this method are not limited to the compounds in Table 1.
以下实例中,涉及到产物ee值的反应均使用手性醇为原料进行了反应对照,涉及到的手性产物的具体结构见表1,但该方法所合成的手性化合物不限于表1的手性化合物。In the following example, the reaction involving the ee value of the product all uses chiral alcohol as the raw material to carry out the reaction control, and the specific structure of the chiral product involved is shown in Table 1, but the chiral compound synthesized by this method is not limited to the chiral compounds in Table 1. Chiral compounds.
以下实例中,涉及到无产物ee值的反应均使用无手性醇或消旋醇为原料。In the following examples, all reactions involving no product ee value use achiral alcohol or racemic alcohol as raw material.
以下实施中,本发明的过程、条件、试剂、实验方法等,在没有特别说明的情况下,均为本领域的常识。In the following implementation, the process, conditions, reagents, experimental methods, etc. of the present invention are common knowledge in the art unless otherwise specified.
以下各实施例中,会产生三甲基硅醇、六甲基二硅醚、碘化钠、碘化钾、碘化铵盐副产物,可通过蒸馏或蒸发结晶方法进行回收利用,但无膦氧副产物和强酸废弃物,在下文中不再对此进行详述。In the following examples, trimethylsilanol, hexamethyldisilazane, sodium iodide, potassium iodide, ammonium iodide salt by-products will be produced, which can be recycled by distillation or evaporative crystallization methods, but no phosphine oxygen by-products are produced. Product and strong acid waste, which will not be described in detail below.
以下实例中,涉及到的性能通过以下方法测试得到的:In the following examples, the performance involved is tested by the following methods:
(1)收率(1) Yield
收率=目标产物的实际生成重量/目标产物的理论生成重量×100%。Yield=actual production weight of target product/theoretical production weight of target product×100%.
(2)ee值(对映体过量值)(2) ee value (enantiomeric excess value)
本发明中产物的对映体过量(ee值的绝对值),是通过手性高效液相色谱方法测试,并按照下述公式进行计算得到。The enantiomeric excess (absolute value of ee value) of the product in the present invention is measured by chiral high performance liquid chromatography and calculated according to the following formula.
ee值=(R-S)/(R+S)×100%ee value=(R-S)/(R+S)×100%
其中,R和S为液相色谱图中S-构型产物与R-构型产物的相应峰的峰面积占比。Wherein, R and S are the peak area ratios of the corresponding peaks of the S-configuration product and the R-configuration product in the liquid chromatogram.
以下实施例中,在没有特别说明的情况下,室温指25±2℃。In the following examples, unless otherwise specified, room temperature refers to 25±2°C.
实施例1AExample 1A
化合物III-1的制备,其结构见表1。The preparation of compound III-1, whose structure is shown in Table 1.
(1)向8mL反应瓶中,加入0.2mmol的消旋的4-苯基-2-丁醇(I-1),1mL二氯甲烷作为溶剂,滴加0.4mmol三甲基碘硅烷,氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) In an 8mL reaction flask, add 0.2mmol of racemic 4-phenyl-2-butanol (I-1), 1mL of dichloromethane as a solvent, dropwise add 0.4mmol of trimethylsilyl iodide, argon Protected at room temperature and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体中加入1mL的DMF,加入0.4mmol的含氮亲核试剂(NaN3,式N-1),氩气保护下60℃反应12小时。反应完全后,加水淬灭,萃取,干燥,柱色谱分离后以94%的收率得到化合物III-1。(2) 1 mL of DMF was added to the iodide intermediate obtained in step (1), 0.4 mmol of nitrogen-containing nucleophile (NaN 3 , formula N-1) was added, and the reaction was carried out at 60° C. for 12 hours under argon protection. After the reaction is complete, add water to quench, extract, dry, and separate by column chromatography to obtain compound III-1 with a yield of 94%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.36–7.23(m,2H),7.23–7.12(m,3H),3.54–3.34(m,1H),2.83–2.57(m,2H),1.87–1.65(m,2H),1.26(d,J=6.5Hz,3H).13C NMR(100MHz,CDCl3)δ141.3,128.56,128.50,126.1,57.2,37.9,32.4,19.5.NMR data: 1 H NMR (400MHz, CDCl 3 )δ7.36-7.23(m,2H), 7.23-7.12(m,3H), 3.54-3.34(m,1H), 2.83-2.57(m,2H), 1.87-1.65 (m, 2H), 1.26 (d, J=6.5Hz, 3H). 13 C NMR (100 MHz, CDCl 3 ) δ 141.3, 128.56, 128.50, 126.1, 57.2, 37.9, 32.4, 19.5.
实施例1BExample 1B
采用与实施例1A相似的方式,不同的是,各反应原料的用量不同,种类与实施例1A相同;In a similar manner to Example 1A, the difference is that the consumption of each reaction raw material is different, and the type is the same as that of Example 1A;
具体的:醇I-1为0.2mmol,三甲基碘硅烷为0.2mmol,含氮亲核试剂NaN3为0.4mmol;Specifically: alcohol I-1 is 0.2 mmol, trimethyliodosilane is 0.2 mmol, and nitrogen-containing nucleophile NaN 3 is 0.4 mmol;
其余均与实施例1A相同,该实施例以75%的收率得到化合物III-1。The rest are the same as in Example 1A, which obtained compound III-1 in a yield of 75%.
实施例1CExample 1C
采用与实施例1A相似的方式,不同的是,各反应原料的用量不同,种类与实施例1A相同;In a similar manner to Example 1A, the difference is that the consumption of each reaction raw material is different, and the type is the same as that of Example 1A;
具体的:醇I-1为0.2mmol,三甲基碘硅烷为0.4mmol,含氮亲核试剂NaN3为0.2mmol;Specifically: alcohol I-1 is 0.2 mmol, trimethyliodosilane is 0.4 mmol, and nitrogen-containing nucleophile NaN 3 is 0.2 mmol;
其余均与实施例1A相同,该实施例以83%的收率得到化合物III-1。The rest are the same as in Example 1A, which obtained compound III-1 in a yield of 83%.
实施例1DExample 1D
采用与实施例1A相似的方式,不同的是,采用等体积的二氧六环代替实施例1A中的二氯甲烷;In a manner similar to that of Example 1A, the difference is that an equal volume of dioxane was used to replace the dichloromethane in Example 1A;
其余均与实施例1A相同,该实施例以80%的收率得到化合物III-1。The rest are the same as in Example 1A, which obtained compound III-1 in a yield of 80%.
实施例1EExample 1E
采用与实施例1A相似的方式,不同的是,采用等摩尔量的三乙基碘硅烷代替实施例1A中的三甲基碘硅烷;In a similar manner as in Example 1A, the difference is that an equimolar amount of triethyliodosilane is used to replace the trimethyliodosilane in Example 1A;
其余均与实施例1A相同,该实施例以52%的收率得到化合物III-1。The rest are the same as in Example 1A, which obtained compound III-1 in a yield of 52%.
实施例1FExample 1F
采用与实施例1A相似的方式,不同的是,采用等摩尔的三苯基碘硅烷代替实施例1A中的三甲基碘硅烷;In a similar manner to Example 1A, the difference is that equimolar triphenyliodosilane is used instead of trimethyliodosilane in Example 1A;
其余均与实施例1A相同,该实施例以35%的收率得到化合物III-1。The rest are the same as in Example 1A, which obtained compound III-1 in a yield of 35%.
实施例1GExample 1G
采用与实施例1A相似的方式,不同的是,反应原料醇为手性醇;In a similar manner to Example 1A, the difference is that the reaction raw material alcohol is a chiral alcohol;
具体的:醇为手性(S)-4-苯基-2-丁醇(S-I-1),其余均与实施例1A相同。Specifically: the alcohol is chiral (S)-4-phenyl-2-butanol (S-I-1), and the rest are the same as those in Example 1A.
得到的碘代物中间体为手性(R)-4-苯基-2-碘丁烷,该实施例以96%的收率,86%ee得到构型保持的化合物S-III-1。The obtained iodide intermediate is chiral (R)-4-phenyl-2-iodobutane, and in this example, the compound S-III-1 with the configuration maintained is obtained with a yield of 96% and an ee of 86%.
实施例2Example 2
化合物III-2的制备,其结构见表1。The preparation of compound III-2, whose structure is shown in Table 1.
(1)8mL反应瓶中加入0.2mmol的醇I-1,1mL二氯甲烷作为溶剂,滴加0.4mmol三甲基碘硅烷,氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) 0.2 mmol of alcohol I-1 was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, 0.4 mmol of trimethyliodosilane was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-2),氩气保护下60℃反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,Na2SO4干燥,柱色谱分离后以91%的收率得到化合物III-2;(2) 1 mL of acetonitrile was added as a solvent, 0.4 mmol of a nitrogen-containing nucleophile (amine, N-2) was added, and the reaction was carried out at 60° C. for 12 hours under argon protection. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry over Na 2 SO 4 , and obtain compound III-2 with a yield of 91% after column chromatography;
核磁数据:1H NMR(400MHz,CDCl3)δ7.32–7.24(m,2H),7.22–7.12(m,3H),2.74–2.45(m,5H),1.84–1.72(m,1H),1.68–1.55(m,1H),1.53–1.40(m,2H),1.38–1.23(m,4H),1.10(d,J=6.3Hz,3H),0.89(t,J=5.8Hz,3H).13C NMR(100MHz,CDCl3)δ142.4,128.3,125.7,52.8,47.3,38.7,32.4,30.1,29.6,22.6,20.4,14.1.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.32-7.24(m,2H),7.22-7.12(m,3H),2.74-2.45(m,5H),1.84-1.72(m,1H), 1.68-1.55(m,1H),1.53-1.40(m,2H),1.38-1.23(m,4H),1.10(d,J=6.3Hz,3H),0.89(t,J=5.8Hz,3H) . 13 C NMR (100MHz, CDCl 3 ) δ 142.4, 128.3, 125.7, 52.8, 47.3, 38.7, 32.4, 30.1, 29.6, 22.6, 20.4, 14.1.
实施例3Example 3
化合物III-3的制备,其结构见表1。The preparation of compound III-3, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-3),氩气保护下60℃反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,Na2SO4干燥,柱色谱分离后以94%的收率得到化合物III-3;(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of a nitrogen-containing nucleophile (amine, N-3), and react at 60° C. for 12 hours under argon protection. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry over Na 2 SO 4 , and obtain compound III-3 with a yield of 94% after column chromatography;
核磁数据:1H NMR(400MHz,CDCl3)δ7.31–7.22(m,2H),7.21–7.12(m,3H),2.78–2.66(m,1H),2.63–2.50(m,5H),2.40–2.27(m,1H),1.98–1.85(m,1H),1.83–1.70(m,4H),1.74–1.61(m,1H),1.15(d,J=6.4Hz,3H).13C NMR(100MHz,CDCl3)δ142.8,128.37,128.34,125.6,58.5,51.2,37.3,32.1,23.5,17.7.NMR data: 1 H NMR (400MHz, CDCl 3 )δ7.31-7.22(m,2H), 7.21-7.12(m,3H), 2.78-2.66(m,1H), 2.63-2.50(m,5H), 13 C NMR (100MHz, CDCl 3 ) δ 142.8, 128.37, 128.34, 125.6, 58.5, 51.2, 37.3, 32.1, 23.5, 17.7.
实施例4Example 4
化合物III-4的制备,其结构见表1。The preparation of compound III-4, whose structure is shown in Table 1.
(1)8mL反应瓶中加入0.2mmol醇(I-1),1mL二氯甲烷作为溶剂,滴加0.4mmol三甲基碘硅烷,氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) 0.2 mmol of alcohol (I-1) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, 0.4 mmol of trimethylsilyl iodide was added dropwise, and the reaction was carried out at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-4),氩气保护下60℃反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,Na2SO4干燥,柱色谱分离后以93%的收率得到化合物III-4;(2) 1 mL of acetonitrile was added as a solvent, 0.4 mmol of a nitrogen-containing nucleophile (amine, N-4) was added, and the reaction was carried out at 60° C. for 12 hours under argon protection. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry over Na 2 SO 4 , and obtain compound III-4 with a yield of 93% after column chromatography;
核磁数据:1H NMR(400MHz,CDCl3)δ7.29–7.22(m,2H),7.21–7.13(m,3H),3.75–3.64(m,4H),2.74–2.59(m,2H),2.58–2.48(m,3H),2.48–2.39(m,2H),1.90–1.79(m,1H),1.62–1.51(m,1H),1.00(d,J=6.6Hz,3H).13C NMR(100MHz,CDCl3)δ142.6,128.47,128.32,125.7,67.5,58.4,48.7,35.3,32.8,13.9.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.29-7.22(m,2H),7.21-7.13(m,3H),3.75-3.64(m,4H),2.74-2.59(m,2H), 13 C NMR (100MHz, CDCl 3 ) δ 142.6, 128.47, 128.32, 125.7, 67.5, 58.4, 48.7, 35.3, 32.8, 13.9.
实施例5Example 5
化合物5的制备,其结构见表1。The preparation of compound 5, whose structure is shown in Table 1.
(1)8mL反应瓶中加入0.2mmol醇(I-1),1mL二氯甲烷作为溶剂,滴加0.4mmol三甲基碘硅烷,氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,加入1mL乙腈作为溶剂,得到碘代物中间体;(1) 0.2 mmol of alcohol (I-1) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, 0.4 mmol of trimethylsilyl iodide was added dropwise, and the reaction was performed at room temperature under argon protection and in the dark for 16 hours. After the reaction was completed, the solvent was evaporated, and 1 mL of acetonitrile was added as the solvent to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体中加入0.4mmol含氮亲核试剂(胺,N-5),氩气保护下60℃反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,Na2SO4干燥,柱色谱分离后以91%的收率得到化合物III-5;(2) 0.4 mmol of nitrogen-containing nucleophile (amine, N-5) was added to the iodide intermediate obtained in step (1), and the reaction was carried out at 60° C. for 12 hours under argon protection. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry over Na 2 SO 4 , and obtain compound III-5 with a yield of 91% after column chromatography;
核磁数据:1H NMR(400MHz,CDCl3)δ7.50–7.25(m,10H),3.72(d,J=13.4Hz,1H),3.57(d,J=13.4Hz,1H),2.93–2.74(m,3H),2.27(s,3H),2.08–1.95(m,1H),1.77–1.65(m,1H),1.14(d,J=6.5Hz,3H).13C NMR(100MHz,CDCl3)δ143.0,140.5,128.81,128.57,128.39,128.29,126.7,125.7,57.61,57.19,36.52,36.13,33.2,13.3.NMR data: 1 H NMR (400MHz, CDCl 3 )δ7.50-7.25(m, 10H), 3.72(d, J=13.4Hz, 1H), 3.57(d, J=13.4Hz, 1H), 2.93-2.74 (m, 3H), 2.27 (s, 3H), 2.08–1.95 (m, 1H), 1.77–1.65 (m, 1H), 1.14 (d, J=6.5Hz, 3H). 13 C NMR (100MHz, CDCl) 3 ) δ143.0, 140.5, 128.81, 128.57, 128.39, 128.29, 126.7, 125.7, 57.61, 57.19, 36.52, 36.13, 33.2, 13.3.
实施例6Example 6
化合物III-6的制备,其结构见表1。The preparation of compound III-6, whose structure is shown in Table 1.
(1)8mL反应瓶中0.2mmol加入醇I-1,1mL二氯甲烷作为溶剂,滴加0.4mmol三甲基碘硅烷,氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) 0.2 mmol of alcohol I-1 was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, 0.4 mmol of trimethylsilyl iodide was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-6),氩气保护下室温回流反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,Na2SO4干燥,柱色谱分离后以93%的收率得到化合物III-6;(2) 1 mL of acetonitrile was added as a solvent, 0.4 mmol of a nitrogen-containing nucleophile (amine, N-6) was added, and the reaction was refluxed at room temperature for 12 hours under argon protection. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry over Na 2 SO 4 , and obtain compound III-6 with a yield of 93% after column chromatography;
核磁数据:1H NMR(400MHz,CDCl3)δ7.31–7.26(m,2H),7.22–7.10(m,5H),6.70–6.63(m,1H),6.57–6.48(m,2H),3.49(h,J=6.3Hz,1H),2.73(t,J=7.9Hz,2H),1.88(dtd,J=14.2,8.0,6.8Hz,1H),1.77(dtd,J=13.9,7.9,6.2Hz,1H),1.55(s,1H),1.22(d,J=6.3Hz,3H).13C NMR(100MHz,CDCl3)δ147.5,141.9,129.2,128.43,128.38,125.8,116.9,113.1,47.8,38.8,32.4,20.8.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.31-7.26(m,2H),7.22-7.10(m,5H),6.70-6.63(m,1H),6.57-6.48(m,2H), 3.49(h,J=6.3Hz,1H),2.73(t,J=7.9Hz,2H),1.88(dtd,J=14.2,8.0,6.8Hz,1H),1.77(dtd,J=13.9,7.9, 6.2Hz, 1H), 1.55(s, 1H), 1.22(d, J=6.3Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ147.5, 141.9, 129.2, 128.43, 128.38, 125.8, 116.9, 113.1, 47.8, 38.8, 32.4, 20.8.
实施例7Example 7
化合物III-7的制备,其结构见表1。The preparation of compound III-7, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-7),氩气保护下室温回流反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,Na2SO4干燥,柱色谱分离后以93%的收率得到化合物III-7,(2) To the iodide intermediate obtained in step (1), 1 mL of acetonitrile was added as a solvent, 0.4 mmol of a nitrogen-containing nucleophile (amine, N-7) was added, and the reaction was refluxed at room temperature for 12 hours under argon protection. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry over Na 2 SO 4 , and obtain compound III-7 with a yield of 93% after column chromatography.
核磁数据:1H NMR(400MHz,CDCl3)δ7.27–7.16(m,5H),7.15(d,J=1.7Hz,2H),6.74(d,J=7.8Hz,2H),6.68(t,J=7.2Hz,1H),3.97–3.86(m,1H),2.75(s,3H),2.68–2.53(m,2H),1.99–1.89(m,1H),1.82–1.71(m,1H),1.12(d,J=6.6Hz,3H).13C NMR(100MHz,CDCl3)δ150.5,142.1,129.1,128.47,128.36,125.8,116.3,113.1,52.7,36.4,33.1,29.8,16.9.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.27-7.16(m, 5H), 7.15(d, J=1.7Hz, 2H), 6.74(d, J=7.8Hz, 2H), 6.68(t , J=7.2Hz, 1H), 3.97–3.86 (m, 1H), 2.75 (s, 3H), 2.68–2.53 (m, 2H), 1.99–1.89 (m, 1H), 1.82–1.71 (m, 1H) ), 1.12(d, J=6.6Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ150.5, 142.1, 129.1, 128.47, 128.36, 125.8, 116.3, 113.1, 52.7, 36.4, 33.1, 29.8, 16.9.
实施例8Example 8
化合物III-8的制备,其结构见表1。The preparation of compound III-8, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-8),氩气保护下室温回流反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,Na2SO4干燥,柱色谱分离后以46%的收率得到化合物III-8,(2) To the iodide intermediate obtained in step (1), 1 mL of acetonitrile was added as a solvent, 0.4 mmol of a nitrogen-containing nucleophile (amine, N-8) was added, and the reaction was refluxed at room temperature for 12 hours under argon protection. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried over Na 2 SO 4 , and separated by column chromatography to obtain compound III-8 with a yield of 46%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.96(s,1H),7.88–7.79(m,1H),7.38–7.33(m,1H),7.31–7.27(m,3H),7.20(t,J=7.2Hz,1H),7.08(d,J=7.3Hz,2H),4.49–4.36(m,1H),2.62–2.47(m,2H),2.45–2.32(m,1H),2.26–2.13(m,1H),1.62(d,J=6.8Hz,3H).13C NMR(100MHz,CDCl3)δ144.1,141.0,140.3,133.2,128.59,128.35,126.3,122.72,122.13,120.5,110.2,51.4,37.8,32.3,21.1.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.96(s,1H),7.88-7.79(m,1H),7.38-7.33(m,1H),7.31-7.27(m,3H),7.20( t, J=7.2Hz, 1H), 7.08 (d, J=7.3Hz, 2H), 4.49–4.36 (m, 1H), 2.62–2.47 (m, 2H), 2.45–2.32 (m, 1H), 2.26 -2.13 (m, 1H), 1.62 (d, J=6.8Hz, 3H). 13 C NMR (100MHz, CDCl 3 ) δ 144.1, 141.0, 140.3, 133.2, 128.59, 128.35, 126.3, 122.72, 122.13, 120.5, 110.2 ,51.4,37.8,32.3,21.1.
实施例9Example 9
化合物III-9的制备,其结构见表1The preparation of compound III-9, its structure is shown in Table 1
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-9),氩气保护下室温回流反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,Na2SO4干燥,柱色谱分离后以29%的收率得到化合物III-9,(2) To the iodide intermediate obtained in step (1), 1 mL of acetonitrile was added as a solvent, 0.4 mmol of a nitrogen-containing nucleophile (amine, N-9) was added, and the reaction was refluxed at room temperature for 12 hours under argon protection. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried over Na 2 SO 4 , and separated by column chromatography to obtain compound III-9 with a yield of 29%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.57(d,J=5.0Hz,1H),7.43(d,J=12.8Hz,1H),7.30(t,J=7.3Hz,2H),7.22(d,J=7.2Hz,1H),7.16(d,J=7.5Hz,2H),6.28(s,1H),4.43–4.28(m,1H),2.54–2.44(m,2H),2.38–2.25(m,1H),2.14–2.01(m,1H),1.54(d,J=6.7Hz,3H).13C NMR(100MHz,CDCl3)δ141.2,138.9,128.4,127.3,125.9,104.8,57.3,38.6,32.2,21.5.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.57(d,J=5.0Hz,1H),7.43(d,J=12.8Hz,1H),7.30(t,J=7.3Hz,2H), 7.22 (d, J=7.2Hz, 1H), 7.16 (d, J=7.5Hz, 2H), 6.28 (s, 1H), 4.43–4.28 (m, 1H), 2.54–2.44 (m, 2H), 2.38 -2.25(m,1H),2.14-2.01(m,1H),1.54(d,J=6.7Hz,3H). 13 C NMR (100MHz, CDCl 3 )δ141.2,138.9,128.4,127.3,125.9,104.8, 57.3, 38.6, 32.2, 21.5.
实施例10Example 10
化合物III-10的制备,其结构见表1。The preparation of compound III-10, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-2(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-2 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was performed at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入K2CO3(0.4mmol),在该实施例中醇I-2部分作为亲核试剂,氩气保护下60℃反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,Na2SO4干燥,柱色谱分离后以80%的收率得到化合物III-10,(2) To the iodide intermediate obtained in step (1), 1 mL of acetonitrile was added as a solvent, K 2 CO 3 (0.4 mmol) was added, and in this example, the alcohol I-2 part was used as a nucleophile, under argon protection at 60° C. The reaction was carried out for 12 hours. After the reaction was completed, the mixture was washed with dichloromethane and saturated brine, dried over Na 2 SO 4 , and separated by column chromatography to obtain compound III-10 with a yield of 80%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.74(d,J=8.0Hz,1H),7.36(d,J=8.3Hz,2H),7.22(t,J=7.7Hz,1H),7.15(d,J=8.0Hz,2H),7.10(t,J=7.5Hz,1H),6.97(d,J=7.3Hz,1H),4.35(h,J=6.5Hz,1H),2.36(s,4H),1.86–1.72(m,2H),1.38–1.30(m,1H),1.28(d,J=6.5Hz,3H).13C NMR(100MHz,CDCl3)δ143.3,136.3,135.1,133.4,129.4,127.98,127.52,127.02,126.6,125.5,52.2,30.0,24.6,21.65,21.54.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.74(d,J=8.0Hz,1H),7.36(d,J=8.3Hz,2H),7.22(t,J=7.7Hz,1H), 7.15(d,J=8.0Hz,2H),7.10(t,J=7.5Hz,1H),6.97(d,J=7.3Hz,1H),4.35(h,J=6.5Hz,1H),2.36( s, 4H), 1.86–1.72 (m, 2H), 1.38–1.30 (m, 1H), 1.28 (d, J=6.5Hz, 3H). 13 C NMR (100 MHz, CDCl 3 ) δ 143.3, 136.3, 135.1, 133.4, 129.4, 127.98, 127.52, 127.02, 126.6, 125.5, 52.2, 30.0, 24.6, 21.65, 21.54.
实施例11Example 11
化合物III-11的制备,其结构见表1。The preparation of compound III-11, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-3(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-3 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL的DMF作为溶剂,加入0.4mmol含氮亲核试剂(NaN3),氩气保护下60℃反应12小时。反应完全后,加水淬灭,萃取,干燥,柱色谱分离后以95%的收率得到化合物III-11,(2) To the iodide intermediate obtained in step (1), add 1 mL of DMF as a solvent, add 0.4 mmol of a nitrogen-containing nucleophile (NaN 3 ), and react at 60° C. for 12 hours under argon protection. After the reaction is complete, add water to quench, extract, dry, and separate by column chromatography to obtain compound III-11 with a yield of 95%,
核磁数据:1H NMR(400MHz,CDCl3)δ7.35–7.29(m,2H),7.21–7.15(m,2H),7.15–7.09(m,1H),5.28(q,J=7.1Hz,1H),2.09(d,J=7.1Hz,3H).13C NMR(100MHz,CDCl3)δ143.1,126.5,125.7,124.4,26.8,24.1.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.35-7.29(m,2H),7.21-7.15(m,2H),7.15-7.09(m,1H),5.28(q,J=7.1Hz, 1H), 2.09 (d, J=7.1Hz, 3H). 13 C NMR (100MHz, CDCl 3 ) δ 143.1, 126.5, 125.7, 124.4, 26.8, 24.1.
实施例12Example 12
化合物III-12的制备,其结构见表1。The preparation of compound III-12, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-4(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-4 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL DMF作为溶剂,加入0.4mmol含氮亲核试剂(NaN3,N-1),氩气保护下60℃反应12小时。反应完全后,加水淬灭,萃取,干燥,柱色谱分离后以93%的收率得到化合物III-12,(2) To the iodide intermediate obtained in step (1), add 1 mL of DMF as a solvent, add 0.4 mmol of a nitrogen-containing nucleophile (NaN 3 , N-1), and react at 60° C. for 12 hours under argon protection. After the reaction is complete, add water to quench, extract, dry, and separate by column chromatography to obtain compound III-12 with a yield of 93%,
核磁数据:1H NMR(400MHz,CDCl3)δ7.45–7.36(m,3H),7.34(d,J=7.2Hz,2H),4.35(s,2H).13C NMR(100MHz,CDCl3)δ135.4,128.89,128.36,128.27,54.8.NMR data: 1 H NMR (400MHz, CDCl 3 )δ7.45-7.36(m, 3H), 7.34(d, J=7.2Hz, 2H), 4.35(s, 2H). 13 C NMR(100MHz, CDCl 3 )δ135.4,128.89,128.36,128.27,54.8.
实施例13Example 13
化合物III-13的制备,其结构见表1。The preparation of compound III-13, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-4(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-4 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-4),氩气保护下60℃反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以90%的收率得到化合物III-13,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of a nitrogen-containing nucleophile (amine, N-4), and react at 60° C. for 12 hours under argon protection. After the reaction was completed, the mixture was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-13 with a yield of 90%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.36–7.27(m,4H),7.26–7.19(m,1H),3.69(t,J=4.7Hz,4H),3.48(s,2H),2.42(t,J=4.7Hz,4H).13C NMR(100MHz,CDCl3)δ137.8,129.2,128.3,127.1,67.0,63.5,53.6.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.36-7.27(m, 4H), 7.26-7.19(m, 1H), 3.69(t, J=4.7Hz, 4H), 3.48(s, 2H) , 2.42 (t, J=4.7Hz, 4H). 13 C NMR (100MHz, CDCl 3 )δ137.8, 129.2, 128.3, 127.1, 67.0, 63.5, 53.6.
实施例14Example 14
化合物III-14的制备,其结构见表1。The preparation of compound III-14, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-4(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-4 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-7),氩气保护下室温回流反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以92%的收率得到化合物III-14,(2) To the iodide intermediate obtained in step (1), 1 mL of acetonitrile was added as a solvent, 0.4 mmol of nitrogen-containing nucleophile (amine, N-7) was added, and the reaction was refluxed at room temperature for 12 hours under argon protection. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-14 with a yield of 92%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.31–7.25(m,2H),7.23–7.16(m,5H),6.75–6.66(m,3H),4.49(s,2H),2.97(s,3H).13C NMR(100MHz,CDCl3)δ149.8,139.1,129.3,128.7,127.0,126.8,116.6,112.5,56.7,38.6.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.31-7.25(m,2H),7.23-7.16(m,5H),6.75-6.66(m,3H),4.49(s,2H),2.97( s, 3H). 13 C NMR (100MHz, CDCl 3 )δ149.8, 139.1, 129.3, 128.7, 127.0, 126.8, 116.6, 112.5, 56.7, 38.6.
实施例15Example 15
化合物III-15的制备,其结构见表1。The preparation of compound III-15, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-5(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-5 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was performed at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL的DMF作为溶剂,加入0.4mmol含氮亲核试剂(NaN3,N-1),氩气保护下60℃反应12小时。反应完全后,加水淬灭,萃取,干燥,柱色谱分离后以94%的收率得到化合物III-15,(2) To the iodide intermediate obtained in step (1), add 1 mL of DMF as a solvent, add 0.4 mmol of a nitrogen-containing nucleophile (NaN 3 , N-1), and react at 60° C. for 12 hours under argon protection. After the reaction is complete, add water to quench, extract, dry, and separate by column chromatography to obtain compound III-15 with a yield of 94%,
核磁数据:1H NMR(400MHz,CDCl3)δ7.40(t,J=7.3Hz,2H),7.35–7.27(m,3H),3.56(t,J=7.3Hz,2H),2.96(t,J=7.3Hz,2H).13C NMR(100MHz,CDCl3)δ138.1,128.83,128.72,126.8,52.5,35.4.Nuclear magnetic data: 1 H NMR (400 MHz, CDCl 3 ) δ 7.40 (t, J=7.3 Hz, 2H), 7.35-7.27 (m, 3H), 3.56 (t, J=7.3 Hz, 2H), 2.96 (t , J=7.3Hz, 2H). 13 C NMR (100MHz, CDCl 3 )δ138.1, 128.83, 128.72, 126.8, 52.5, 35.4.
实施例16Example 16
化合物III-16的制备,其结构见表1。The preparation of compound III-16, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-5(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-5 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was performed at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-10),氩气保护下60℃反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以58%的收率得到化合物III-16,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of a nitrogen-containing nucleophile (amine, N-10), and react at 60° C. for 12 hours under argon protection. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-16 with a yield of 58%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.37–7.27(m,4H),7.27–7.17(m,6H),2.95–2.87(m,2H),2.87–2.80(m,2H),2.72–2.57(m,4H),1.66(p,J=8.3,7.7Hz,2H),1.55(p,J=7.2Hz,2H),1.33(s,1H).13C NMR(100MHz,CDCl3)δ142.4,140.1,128.74,128.49,128.43,128.29,126.1,125.7,51.2,49.7,36.4,35.8,29.77,29.21.NMR data: 1 H NMR (400MHz, CDCl 3 )δ7.37-7.27(m,4H), 7.27-7.17(m,6H), 2.95-2.87(m,2H), 2.87-2.80(m,2H), 2.72–2.57 (m, 4H), 1.66 (p, J=8.3, 7.7Hz, 2H), 1.55 (p, J=7.2Hz, 2H), 1.33 (s, 1H). 13 C NMR (100MHz, CDCl 3 )δ142.4,140.1,128.74,128.49,128.43,128.29,126.1,125.7,51.2,49.7,36.4,35.8,29.77,29.21.
实施例17Example 17
化合物III-17的制备,其结构见表1。The preparation of compound III-17, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-5(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-5 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was performed at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-3),氩气保护下60℃反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以93%的收率得到化合物III-17,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of a nitrogen-containing nucleophile (amine, N-3), and react at 60° C. for 12 hours under argon protection. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-17 with a yield of 93%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.31–7.24(m,2H),7.24–7.15(m,4H),2.87–2.79(m,2H),2.72–2.63(m,2H),2.59–2.48(m,4H),1.85–1.74(m,4H).13C NMR(100MHz,CDCl3)δ140.5,129.0,128.68,128.51,128.40,126.0,63.4,58.4,54.2,39.5,35.8,23.4.NMR data: 1 H NMR (400MHz, CDCl 3 )δ7.31-7.24(m,2H), 7.24-7.15(m,4H), 2.87-2.79(m,2H), 2.72-2.63(m,2H), 2.59–2.48 (m, 4H), 1.85–1.74 (m, 4H). 13 C NMR (100 MHz, CDCl 3 ) δ 140.5, 129.0, 128.68, 128.51, 128.40, 126.0, 63.4, 58.4, 54.2, 39.5, 35.8, 23.4 .
实施例18Example 18
化合物18的制备,其结构见表1。The preparation of compound 18, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-5(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-5 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was performed at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-6),氩气保护下室温回流反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以88%的收率得到化合物III-18,(2) To the iodide intermediate obtained in step (1), 1 mL of acetonitrile was added as a solvent, 0.4 mmol of a nitrogen-containing nucleophile (amine, N-6) was added, and the reaction was refluxed at room temperature for 12 hours under argon protection. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-18 with a yield of 88%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.35–7.28(m,2H),7.24–7.14(m,5H),6.71(t,J=7.2Hz,1H),6.61(d,J=7.8Hz,2H),3.40(t,J=7.0Hz,2H),2.91(t,J=6.9Hz,2H).13CNMR(100MHz,CDCl3)δ148.0,139.33,129.32,128.82,128.63,126.4,117.5,113.0,45.0,35.5.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.35-7.28(m, 2H), 7.24-7.14(m, 5H), 6.71(t, J=7.2Hz, 1H), 6.61(d, J= 7.8Hz, 2H), 3.40 (t, J=7.0Hz, 2H), 2.91 (t, J=6.9Hz, 2H). 13 CNMR (100MHz, CDCl 3 )δ148.0, 139.33, 129.32, 128.82, 128.63, 126.4, 117.5, 113.0, 45.0, 35.5.
实施例19Example 19
化合物III-19的制备,其结构见表1。The preparation of compound III-19, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-5(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-5 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was performed at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氮亲核试剂(胺,N-7),氩气保护下室温回流反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以58%的收率得到化合物III-19,(2) To the iodide intermediate obtained in step (1), 1 mL of acetonitrile was added as a solvent, 0.4 mmol of a nitrogen-containing nucleophile (amine, N-7) was added, and the reaction was refluxed at room temperature for 12 hours under argon protection. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-19 with a yield of 58%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.34–7.17(m,7H),6.77–6.67(m,3H),3.56(t,J=7.6Hz,2H),2.88(s,3H),2.84(t,J=7.6Hz,2H).13C NMR(100MHz,CDCl3)δ148.8,139.8,129.3,128.86,128.58,126.2,116.2,112.1,54.8,38.5,32.9.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.34-7.17(m, 7H), 6.77-6.67(m, 3H), 3.56(t, J=7.6Hz, 2H), 2.88(s, 3H) , 2.84 (t, J=7.6Hz, 2H). 13 C NMR (100MHz, CDCl 3 )δ148.8, 139.8, 129.3, 128.86, 128.58, 126.2, 116.2, 112.1, 54.8, 38.5, 32.9.
以下实施例用于说明硫化反应产物的制备。The following examples serve to illustrate the preparation of the sulfurization reaction product.
实施例20Example 20
化合物20的制备,其结构见表1。The preparation of compound 20, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含硫亲核试剂(硫醇,S-1)和K2CO3(0.4mmol),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以52%的收率得到化合物III-20,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of sulfur-containing nucleophile (thiol, S-1) and K 2 CO 3 (0.4 mmol), under argon protection at room temperature The reaction was carried out for 6 hours. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-20 with a yield of 52%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.32–7.24(m,4H),7.23–7.15(m,6H),2.89–2.82(m,2H),2.81–2.65(m,5H),1.94–1.73(m,2H),1.31(d,J=6.7Hz,3H).13C NMR(100MHz,CDCl3)δ141.9,140.8,128.49,128.46,128.42,126.3,125.8,39.5,38.6,36.5,33.2,31.7,21.5.NMR data: 1 H NMR (400MHz, CDCl 3 )δ7.32-7.24(m,4H), 7.23-7.15(m,6H), 2.89-2.82(m,2H), 2.81-2.65(m,5H), 1.94-1.73(m, 2H), 1.31(d, J=6.7Hz, 3H). 13 C NMR (100 MHz, CDCl 3 ) δ 141.9, 140.8, 128.49, 128.46, 128.42, 126.3, 125.8, 39.5, 38.6, 36.5, 33.2, 31.7, 21.5.
实施例21Example 21
化合物21的制备,其结构见表1。The preparation of compound 21, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL的DMF作为溶剂,加入0.4mmol含硫亲核试剂(苯硫酚钠,S-2),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以90%的收率得到化合物III-21,(2) To the iodide intermediate obtained in step (1), add 1 mL of DMF as a solvent, add 0.4 mmol of a sulfur-containing nucleophile (sodium thiophenate, S-2), and react at room temperature for 6 hours under argon protection. After the reaction was completed, the mixture was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-21 with a yield of 90%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.38–7.32(m,2H),7.29–7.22(m,4H),7.22–7.14(m,4H),3.19(h,J=6.7Hz,1H),2.83–2.72(m,2H),1.92(ddt,J=13.6,9.0,6.7Hz,1H),1.81(ddt,J=13.7,9.1,6.7Hz,1H),1.31(d,J=6.7Hz,3H).13C NMR(100MHz,CDCl3)δ141.7,135.1,132.0,128.88,128.54,128.47,126.8,125.9,42.5,38.2,33.2,21.2.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.38-7.32(m,2H),7.29-7.22(m,4H),7.22-7.14(m,4H),3.19(h,J=6.7Hz, 1H), 2.83–2.72 (m, 2H), 1.92 (ddt, J=13.6, 9.0, 6.7Hz, 1H), 1.81 (ddt, J=13.7, 9.1, 6.7Hz, 1H), 1.31 (d, J= 6.7Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ141.7, 135.1, 132.0, 128.88, 128.54, 128.47, 126.8, 125.9, 42.5, 38.2, 33.2, 21.2.
实施例22AExample 22A
化合物III-22的制备,其结构见表1。The preparation of compound III-22, whose structure is shown in Table 1.
(1)8mL反应瓶中加入手性醇S-I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Chiral alcohol S-I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含硫亲核试剂(取代苯硫酚,S-3)和K2CO3(0.4mmol),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以96%的收率,96%ee得到化合物III-22,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of sulfur-containing nucleophile (substituted thiophenol, S-3) and K 2 CO 3 (0.4 mmol), under argon protection The reaction was carried out at room temperature for 6 hours. After the reaction is complete, use dichloromethane and saturated brine to wash, dry, and obtain compound III-22 with a yield of 96%, 96% ee after column chromatography,
核磁数据:1H NMR(400MHz,CDCl3)δ7.31–7.24(m,3H),7.21–7.14(m,4H),7.14–7.08(m,2H),3.21(h,J=6.7Hz,1H),2.86–2.72(m,2H),2.39(s,3H),1.97(ddt,J=13.4,9.2,6.6Hz,1H),1.85(ddt,J=13.7,9.1,6.7Hz,1H),1.32(d,J=6.7Hz,3H).13C NMR(100MHz,CDCl3)δ141.6,139.3,134.8,131.2,130.2,128.48,128.41,126.46,126.26,125.9,41.7,38.3,33.1,21.0,20.8.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.31-7.24(m,3H),7.21-7.14(m,4H),7.14-7.08(m,2H),3.21(h,J=6.7Hz, 1H), 2.86–2.72 (m, 2H), 2.39 (s, 3H), 1.97 (ddt, J=13.4, 9.2, 6.6Hz, 1H), 1.85 (ddt, J=13.7, 9.1, 6.7Hz, 1H) , 1.32 (d, J=6.7Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ141.6, 139.3, 134.8, 131.2, 130.2, 128.48, 128.41, 126.46, 126.26, 125.9, 41.7, 38.3, 33.1, 21.0, 20.8.
实施例22BExample 22B
采用与实施例22A相似的方式,不同的是,采用等体积的二氯甲烷代替实施例22A中步骤(2)中的乙腈作为溶剂;In a manner similar to that of Example 22A, the difference is that an equal volume of dichloromethane was used to replace the acetonitrile in step (2) in Example 22A as the solvent;
其余均与实施例22A相同,该实施例以87%的收率,88%ee得到化合物S-III-22。The rest are the same as in Example 22A, which obtained compound S-III-22 with a yield of 87% and 88% ee.
实施例22CExample 22C
采用与实施例22A相似的方式,不同的是,室温回流2小时代替实施例22A中步骤(2)中的室温反应6小时;In a manner similar to that of Example 22A, the difference is that the room temperature reaction in step (2) in Example 22A was substituted for 6 hours by refluxing at room temperature for 2 hours;
其余均与实施例22A相同,该实施例以95%的收率,25%ee得到化合物S-III-22。The rest are the same as in Example 22A, which obtained compound S-III-22 with a yield of 95% and 25% ee.
实施例22DExample 22D
采用与实施例22A相似的方式,不同的是,使用等摩尔量的消旋的醇代替实施例22A中的手性醇;In a similar manner to Example 22A, except that an equimolar amount of racemic alcohol was used instead of the chiral alcohol in Example 22A;
其余均与实施例22A相同,该实施例以95%的收率得到消旋的化合物III-22。The rest are the same as in Example 22A, which obtained the racemic compound III-22 in a yield of 95%.
实施例23Example 23
化合物III-23的制备,其结构见表1。The preparation of compound III-23, whose structure is shown in Table 1.
(1)8mL反应瓶中加入手性醇S-I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Chiral alcohol S-I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含硫亲核试剂(取代苯硫酚,S-4)和K2CO3(0.4mmol),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以86%的收率,94%ee得到化合物S-III-23,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of sulfur-containing nucleophile (substituted thiophenol, S-4) and K 2 CO 3 (0.4 mmol), under argon protection The reaction was carried out at room temperature for 6 hours. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound S-III-23 with a yield of 86%, 94% ee,
核磁数据:1H NMR(400MHz,CDCl3)δ7.25(d,J=7.4Hz,5H),7.21–7.12(m,3H),7.08(d,J=7.8Hz,2H),3.10(h,J=6.7Hz,1H),2.85–2.69(m,2H),2.31(s,3H),1.96–1.83(m,1H),1.83–1.71(m,1H),1.28(d,J=6.8Hz,3H).13C NMR(100MHz,CDCl3)δ141.7,137.0,132.9,131.0,129.5,128.47,128.38,125.8,43.0,38.1,33.2,21.2,21.1.Nuclear magnetic data: 1 H NMR (400 MHz, CDCl 3 ) δ 7.25 (d, J=7.4 Hz, 5H), 7.21-7.12 (m, 3H), 7.08 (d, J=7.8 Hz, 2H), 3.10 (h) , J=6.7Hz, 1H), 2.85–2.69 (m, 2H), 2.31 (s, 3H), 1.96–1.83 (m, 1H), 1.83–1.71 (m, 1H), 1.28 (d, J=6.8 Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ141.7, 137.0, 132.9, 131.0, 129.5, 128.47, 128.38, 125.8, 43.0, 38.1, 33.2, 21.2, 21.1.
实施例24Example 24
化合物III-24的制备,其结构见表1。The preparation of compound III-24, whose structure is shown in Table 1.
(1)8mL反应瓶中加入手性醇S-I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Chiral alcohol S-I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含硫亲核试剂(取代苯硫酚,S-5)和K2CO3(0.4mmol),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以92%的收率,96%ee得到化合物S-III-24,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of sulfur-containing nucleophile (substituted thiophenol, S-5) and K 2 CO 3 (0.4 mmol), under argon protection The reaction was carried out at room temperature for 6 hours. After the reaction is complete, use dichloromethane and saturated brine to wash, dry, and obtain compound S-III-24 with a yield of 92% and 96% ee after column chromatography.
核磁数据:1H NMR(400MHz,CDCl3)δ7.47–7.38(m,2H),7.37–7.28(m,2H),7.28–7.17(m,3H),7.03(t,J=8.4Hz,2H),3.13(h,J=6.7Hz,1H),2.92–2.75(m,2H),2.04–1.75(m,2H),1.33(d,J=6.8Hz,3H).13C NMR(100MHz,CDCl3)δ162.3(d,J=247.3Hz),141.6,135.1(d,J=8.1Hz),129.6(d,J=3.4Hz),128.4,125.9,115.9(d,J=21.7Hz),43.5,38.0,33.1,21.1.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.47-7.38(m,2H),7.37-7.28(m,2H),7.28-7.17(m,3H),7.03(t,J=8.4Hz, 2H), 3.13 (h, J=6.7Hz, 1H), 2.92–2.75 (m, 2H), 2.04–1.75 (m, 2H), 1.33 (d, J=6.8Hz, 3H). 13 C NMR (100MHz) , CDCl 3 )δ162.3(d,J=247.3Hz),141.6,135.1(d,J=8.1Hz),129.6(d,J=3.4Hz),128.4,125.9,115.9(d,J=21.7Hz ), 43.5, 38.0, 33.1, 21.1.
实施例25Example 25
化合物III-25的制备,其结构见表1。The preparation of compound III-25, whose structure is shown in Table 1.
(1)8mL反应瓶中加入手性醇S-I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Chiral alcohol S-I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含硫亲核试剂(取代苯硫酚,S-6)和K2CO3(0.4mmol),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以91%的收率,96%ee得到化合物S-III-25,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of sulfur-containing nucleophile (substituted thiophenol, S-6) and K 2 CO 3 (0.4 mmol), under argon protection The reaction was carried out at room temperature for 6 hours. After the completion of the reaction, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound S-III-25 with a yield of 91%, 96% ee,
核磁数据:1H NMR(400MHz,CDCl3)δ7.31–7.18(m,7H),7.18–7.13(m,2H),3.15(h,J=6.7Hz,1H),2.85–2.69(m,2H),1.91(ddt,J=13.4,9.0,6.6Hz,1H),1.81(ddt,J=13.8,9.0,6.7Hz,1H),1.30(d,J=6.7Hz,3H).13C NMR(100MHz,CDCl3)δ141.4,133.63,133.32,132.8,128.97,128.46,126.0,42.7,38.1,33.1,21.0.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.31-7.18(m,7H),7.18-7.13(m,2H),3.15(h,J=6.7Hz,1H),2.85-2.69(m, 2H), 1.91 (ddt, J=13.4, 9.0, 6.6Hz, 1H), 1.81 (ddt, J=13.8, 9.0, 6.7Hz, 1H), 1.30 (d, J=6.7Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ141.4,133.63,133.32,132.8,128.97,128.46,126.0,42.7,38.1,33.1,21.0.
实施例26Example 26
化合物III-26的制备,其结构见表1。The preparation of compound III-26, whose structure is shown in Table 1.
(1)8mL反应瓶中加入手性醇S-I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Chiral alcohol S-I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含硫亲核试剂(取代苯硫酚,S-7)和K2CO3(0.4mmol),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以90%的收率,98%ee得到化合物S-III-26,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of sulfur-containing nucleophile (substituted thiophenol, S-7) and K 2 CO 3 (0.4 mmol), under argon protection The reaction was carried out at room temperature for 6 hours. After the reaction is complete, use dichloromethane and saturated brine to wash, dry, and obtain compound S-III-26 with 90% yield and 98% ee after column chromatography.
核磁数据:1H NMR(400MHz,CDCl3)δ7.41(d,J=8.5Hz,2H),7.35–7.27(m,3H),7.25–7.16(m,4H),3.19(h,J=6.7Hz,1H),2.89–2.72(m,2H),1.94(ddt,J=13.5,8.9,6.6Hz,1H),1.84(ddt,J=13.6,8.7,6.7Hz,1H),1.34(d,J=6.7Hz,3H).13C NMR(100MHz,CDCl3)δ141.4,134.3,133.4,132.5,131.8,128.4,126.0,120.7,42.6,38.1,33.1,21.0.Nuclear magnetic data: 1 H NMR (400 MHz, CDCl 3 ) δ 7.41 (d, J=8.5 Hz, 2H), 7.35-7.27 (m, 3H), 7.25-7.16 (m, 4H), 3.19 (h, J= 6.7Hz, 1H), 2.89–2.72 (m, 2H), 1.94 (ddt, J=13.5, 8.9, 6.6Hz, 1H), 1.84 (ddt, J=13.6, 8.7, 6.7Hz, 1H), 1.34 (d , J=6.7Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ141.4, 134.3, 133.4, 132.5, 131.8, 128.4, 126.0, 120.7, 42.6, 38.1, 33.1, 21.0.
实施例27Example 27
化合物III-27的制备,其结构见表1。The preparation of compound III-27, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-4(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-4 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入含硫亲核试剂取代苯硫酚S-5(0.4mmol)和K2CO3(0.4mmol),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以91%的收率得到化合物III-27,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add sulfur-containing nucleophile substituted thiophenol S-5 (0.4 mmol) and K 2 CO 3 (0.4 mmol), under argon protection The reaction was carried out at room temperature for 6 hours. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-27 with a yield of 91%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.29–7.18(m,7H),6.97–6.89(m,2H),4.02(s,2H).13C NMR(100MHz,CDCl3)δ162.1(d,J=246.6Hz),137.5,133.4(d,J=8.1Hz),130.7(d,J=3.3Hz),128.87,128.49,127.2,115.9(d,J=21.9Hz),40.4.Nuclear magnetic data: 1 H NMR(400MHz, CDCl 3 )δ7.29-7.18(m,7H),6.97-6.89(m,2H),4.02(s,2H). 13C NMR(100MHz, CDCl 3 )δ162. 1(d,J=246.6Hz),137.5,133.4(d,J=8.1Hz),130.7(d,J=3.3Hz),128.87,128.49,127.2,115.9(d,J=21.9Hz),40.4.
实施例28Example 28
化合物III-28的制备,其结构见表1。The preparation of compound III-28, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-5(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-5 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was performed at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含硫亲核试剂(取代苯硫酚,S-5)和K2CO3(0.4mmol),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以90%的收率得到化合物III-28,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of sulfur-containing nucleophile (substituted thiophenol, S-5) and K 2 CO 3 (0.4 mmol), under argon protection The reaction was carried out at room temperature for 6 hours. After the completion of the reaction, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-28 with a yield of 90%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.63–7.56(m,2H),7.56–7.50(m,2H),7.49–7.39(m,3H),7.28–7.20(m,2H),3.35(dd,J=9.2,6.5Hz,2H),3.13(dd,J=9.3,6.4Hz,2H).13C NMR(100MHz,CDCl3)δ161.8(d,J=246.3Hz),140.0,132.3(d,J=7.8Hz),131.1(d,J=3.4Hz),128.56,128.54,126.5,116.0(d,J=21.9Hz),36.5,35.7.NMR data: 1 H NMR (400MHz, CDCl 3 )δ7.63-7.56(m,2H),7.56-7.50(m,2H),7.49-7.39(m,3H),7.28-7.20(m,2H), 3.35 (dd, J=9.2, 6.5 Hz, 2H), 3.13 (dd, J=9.3, 6.4 Hz, 2H). 13 C NMR (100 MHz, CDCl 3 ) δ 161.8 (d, J=246.3 Hz), 140.0 ,132.3(d,J=7.8Hz),131.1(d,J=3.4Hz),128.56,128.54,126.5,116.0(d,J=21.9Hz),36.5,35.7.
实施例29Example 29
化合物29的制备,其结构见表1。The preparation of compound 29, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含硫亲核试剂(S-8)和K2CO3(0.4mmol),氩气保护下室温反应6小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以88%的收率得到化合物III-29,(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of sulfur-containing nucleophile (S-8) and K 2 CO 3 (0.4 mmol), and react at room temperature for 6 hours under argon protection . After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-29 with a yield of 88%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.67–7.60(m,1H),7.49–7.42(m,1H),7.35–7.24(m,5H),7.23(d,J=7.3Hz,3H),3.98(h,J=6.8Hz,1H),2.94–2.78(m,2H),2.24–2.01(m,2H),1.62(d,J=6.8Hz,3H).13C NMR(100MHz,CDCl3)δ164.5,151.6,142.0,141.1,128.50,128.43,126.1,124.2,123.8,118.4,109.8,42.9,38.3,33.2,21.8.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.67-7.60(m,1H),7.49-7.42(m,1H),7.35-7.24(m,5H),7.23(d,J=7.3Hz, 3H), 3.98 (h, J=6.8Hz, 1H), 2.94–2.78 (m, 2H), 2.24–2.01 (m, 2H), 1.62 (d, J=6.8Hz, 3H). 13 C NMR (100MHz) , CDCl 3 )δ164.5,151.6,142.0,141.1,128.50,128.43,126.1,124.2,123.8,118.4,109.8,42.9,38.3,33.2,21.8.
实施例30Example 30
化合物III-30的制备,其结构见表1。The preparation of compound III-30, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL的DMF作为溶剂,加入0.4mmol含硫亲核试剂(苯亚磺酸钠,S-9),氩气保护下室温反应10小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以66%的收率得到化合物III-30,(2) To the iodide intermediate obtained in step (1), add 1 mL of DMF as a solvent, add 0.4 mmol of a sulfur-containing nucleophile (sodium benzene sulfinate, S-9), and react at room temperature for 10 hours under argon protection. After the reaction was completed, it was washed with dichloromethane and saturated brine, dried, and separated by column chromatography to obtain compound III-30 with a yield of 66%.
核磁数据:1H NMR(400MHz,CDCl3)δ7.90–7.83(m,2H),7.70–7.64(m,1H),7.61–7.54(m,2H),7.33–7.26(m,2H),7.25–7.19(m,1H),7.16–7.10(m,2H),3.11–3.00(m,1H),2.90–2.79(m,1H),2.67–2.56(m,1H),2.40–2.28(m,1H),1.81–1.69(m,1H),1.34(d,J=6.9Hz,3H).13C NMR(100MHz,CDCl3)δ140.1,137.1,133.6,129.13,129.00,128.61,128.32,126.3,59.1,32.4,30.7,13.2.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.90-7.83(m,2H),7.70-7.64(m,1H),7.61-7.54(m,2H),7.33-7.26(m,2H), 7.25–7.19 (m, 1H), 7.16–7.10 (m, 2H), 3.11–3.00 (m, 1H), 2.90–2.79 (m, 1H), 2.67–2.56 (m, 1H), 2.40–2.28 (m , 1H), 1.81–1.69(m, 1H), 1.34(d, J=6.9Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ140.1, 137.1, 133.6, 129.13, 129.00, 128.61, 128.32, 126.3, 59.1, 32.4, 30.7, 13.2.
以下实施例用于说明本发明氧化反应产物的制备The following examples are used to illustrate the preparation of the oxidation reaction product of the present invention
实施例31Example 31
化合物III-31的制备,其结构见表1。The preparation of compound III-31, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL的DMF作为溶剂,加入0.4mmol含氧亲核试剂(醋酸钾,O-1),氩气保护下室温反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以90%的收率得到化合物III-31;(2) To the iodide intermediate obtained in step (1), add 1 mL of DMF as a solvent, add 0.4 mmol of an oxygen-containing nucleophile (potassium acetate, O-1), and react at room temperature for 12 hours under argon protection. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry, and obtain compound III-31 with a yield of 90% after column chromatography;
核磁数据:1H NMR(400MHz,CDCl3)δ7.31–7.25(m,2H),7.22–7.15(m,3H),4.99–4.89(m,1H),2.72–2.56(m,2H),2.03(s,3H),1.99–1.88(m,1H),1.86–1.75(m,1H),1.25(d,J=6.3Hz,3H).13C NMR(100MHz,CDCl3)δ170.8,141.5,128.43,128.32,125.9,70.5,37.5,31.8,21.3,20.0.NMR data: 1 H NMR (400MHz, CDCl 3 )δ7.31-7.25(m,2H), 7.22-7.15(m,3H), 4.99-4.89(m,1H), 2.72-2.56(m,2H), 2.03(s, 3H), 1.99-1.88(m, 1H), 1.86-1.75(m, 1H), 1.25(d, J=6.3Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ170.8,141.5, 128.43, 128.32, 125.9, 70.5, 37.5, 31.8, 21.3, 20.0.
实施例32Example 32
化合物III-32的制备,其结构见表1。The preparation of compound III-32, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL的DMF作为溶剂,加入0.4mmol含氧亲核试剂(苯甲酸钠,O-2),氩气保护下室温反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以92%的收率得到化合物III-32;(2) To the iodide intermediate obtained in step (1), add 1 mL of DMF as a solvent, add 0.4 mmol of an oxygen-containing nucleophile (sodium benzoate, O-2), and react at room temperature for 12 hours under argon protection. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry, and obtain compound III-32 with a yield of 92% after column chromatography;
核磁数据:1H NMR(400MHz,CDCl3)δ8.11(d,J=7.4Hz,2H),7.61(t,J=7.4Hz,1H),7.49(t,J=7.6Hz,2H),7.37–7.30(m,2H),7.28–7.20(m,3H),5.31–5.20(m,1H),2.88–2.72(m,2H),2.23–2.10(m,1H),2.06–1.95(m,1H),1.44(d,J=6.2Hz,3H).13C NMR(100MHz,CDCl3)δ166.2,141.5,132.8,130.8,129.5,128.50,128.40,128.37,125.9,71.2,37.8,31.9,20.2.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 ) δ 8.11 (d, J=7.4Hz, 2H), 7.61 (t, J=7.4Hz, 1H), 7.49 (t, J=7.6Hz, 2H), 7.37–7.30 (m, 2H), 7.28–7.20 (m, 3H), 5.31–5.20 (m, 1H), 2.88–2.72 (m, 2H), 2.23–2.10 (m, 1H), 2.06–1.95 (m , 1H), 1.44 (d, J=6.2Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ166.2, 141.5, 132.8, 130.8, 129.5, 128.50, 128.40, 128.37, 125.9, 71.2, 37.8, 31.9, 20.2 .
实施例33Example 33
化合物III-33的制备,其结构见表1。The preparation of compound III-33, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加三甲基碘硅烷(0.4mmol),氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, trimethylsilyl iodide (0.4 mmol) was added dropwise, and the reaction was carried out at room temperature under argon protection and protected from light for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol含氧亲核试剂(式O-3)和K2CO3(0.4mmol),氩气保护下室温反应12小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以88%的收率得到化合物III-33;(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of an oxygen-containing nucleophile (formula O-3) and K 2 CO 3 (0.4 mmol), and react at room temperature under argon protection for 12 Hour. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry, and obtain compound III-33 with a yield of 88% after column chromatography;
核磁数据:1H NMR(400MHz,CDCl3)δ7.30–7.23(m,2H),7.20–7.14(m,3H),6.81(s,4H),4.28–4.16(m,1H),3.75(s,3H),2.85–2.67(m,2H),2.10–1.97(m,1H),1.90–1.80(m,1H),1.28(d,J=6.1Hz,3H).13C NMR(100MHz,CDCl3)δ153.9,152.1,141.9,128.53,128.42,125.8,117.4,114.7,74.0,55.7,38.3,31.8,19.8.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.30-7.23(m,2H),7.20-7.14(m,3H),6.81(s,4H),4.28-4.16(m,1H),3.75( s, 3H), 2.85–2.67 (m, 2H), 2.10–1.97 (m, 1H), 1.90–1.80 (m, 1H), 1.28 (d, J=6.1Hz, 3H). 13 C NMR (100MHz, CDCl 3 )δ153.9,152.1,141.9,128.53,128.42,125.8,117.4,114.7,74.0,55.7,38.3,31.8,19.8.
实施例34Example 34
化合物III-34的制备,其结构见表1。The preparation of compound III-34, whose structure is shown in Table 1.
(1)8mL反应瓶中加入醇I-1(0.2mmol),1mL二氯甲烷作为溶剂,滴加0.4mmol三甲基碘硅烷,氩气保护下室温并避光反应16小时。待反应完全后,蒸去溶剂,得到碘代物中间体;(1) Alcohol I-1 (0.2 mmol) was added to an 8 mL reaction flask, 1 mL of dichloromethane was used as a solvent, 0.4 mmol of trimethylsilyl iodide was added dropwise, and the reaction was performed at room temperature under argon protection and in the dark for 16 hours. After the reaction is complete, the solvent is evaporated to obtain the iodide intermediate;
(2)向步骤(1)得到碘代物中间体加入1mL乙腈作为溶剂,加入0.4mmol的含氧亲核试剂(苄醇,O-4)和0.8mmol的Ag2O,氩气保护下70℃反应14小时。反应完全后,使用二氯甲烷和饱和食盐水萃洗,干燥,柱色谱分离后以61%的收率得到化合物III-34;(2) To the iodide intermediate obtained in step (1), add 1 mL of acetonitrile as a solvent, add 0.4 mmol of oxygen-containing nucleophile (benzyl alcohol, O-4) and 0.8 mmol of Ag 2 O, under argon protection at 70° C. React for 14 hours. After the reaction is complete, use dichloromethane and saturated brine to extract and wash, dry, and obtain compound III-34 with a yield of 61% after column chromatography;
核磁数据:1H NMR(400MHz,CDCl3)δ7.43–7.36(m,4H),7.35–7.29(m,3H),7.21(ddd,J=7.6,5.3,1.7Hz,3H),4.62(d,J=11.7Hz,1H),4.49(d,J=11.7Hz,1H),3.63–3.52(m,1H),2.81(ddd,J=13.7,9.9,5.6Hz,1H),2.70(ddd,J=13.8,9.8,6.5Hz,1H),1.97(dddd,J=13.8,9.8,7.3,5.6Hz,1H),1.80(dddd,J=13.7,9.9,6.5,4.9Hz,1H),1.27(d,J=6.1Hz,3H).13C NMR(100MHz,CDCl3)δ142.4,139.0,128.46,128.38,128.35,127.72,127.47,125.7,74.1,70.3,38.4,31.8,19.6.Nuclear magnetic data: 1 H NMR (400MHz, CDCl 3 )δ7.43-7.36(m,4H),7.35-7.29(m,3H),7.21(ddd,J=7.6,5.3,1.7Hz,3H),4.62( d, J=11.7Hz, 1H), 4.49 (d, J=11.7Hz, 1H), 3.63–3.52 (m, 1H), 2.81 (ddd, J=13.7, 9.9, 5.6Hz, 1H), 2.70 (ddd ,J=13.8,9.8,6.5Hz,1H),1.97(dddd,J=13.8,9.8,7.3,5.6Hz,1H),1.80(dddd,J=13.7,9.9,6.5,4.9Hz,1H),1.27 (d, J=6.1 Hz, 3H). 13 C NMR (100 MHz, CDCl 3 ) δ 142.4, 139.0, 128.46, 128.38, 128.35, 127.72, 127.47, 125.7, 74.1, 70.3, 38.4, 31.8, 19.6.
表1:各实施例反应原料、产物结构式和收率Table 1: Reaction raw materials, product structural formula and yield of each embodiment
从上述看出,本发明提供了一种操作简便、易于纯化处理的醇脱氧官能化方法,本发明的方法底物适用范围更广,可使用多种亲核试剂。并且,与部分亲核试剂反应能够保持原料醇的构型。It can be seen from the above that the present invention provides an alcohol deoxyfunctionalization method that is easy to operate and easy to purify. Moreover, the reaction with a partial nucleophile can maintain the configuration of the starting alcohol.
以上详细描述了本发明的优选实施方式,但是,本发明并不限于此。在本发明的技术构思范围内,可以对本发明的技术方案进行多种简单变型,包括各个技术特征以任何其它的合适方式进行组合,这些简单变型和组合同样应当视为本发明所公开的内容,均属于本发明的保护范围。The preferred embodiments of the present invention have been described above in detail, however, the present invention is not limited thereto. Within the scope of the technical concept of the present invention, a variety of simple modifications can be made to the technical solutions of the present invention, including combining various technical features in any other suitable manner. These simple modifications and combinations should also be regarded as the content disclosed in the present invention. All belong to the protection scope of the present invention.
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110014657.3A CN114716345A (en) | 2021-01-06 | 2021-01-06 | Method for deoxygenation functionalization and deoxygenation activation of alcohols and alcohol-functionalized materials |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110014657.3A CN114716345A (en) | 2021-01-06 | 2021-01-06 | Method for deoxygenation functionalization and deoxygenation activation of alcohols and alcohol-functionalized materials |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114716345A true CN114716345A (en) | 2022-07-08 |
Family
ID=82234047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110014657.3A Pending CN114716345A (en) | 2021-01-06 | 2021-01-06 | Method for deoxygenation functionalization and deoxygenation activation of alcohols and alcohol-functionalized materials |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114716345A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6448256B1 (en) * | 1999-05-24 | 2002-09-10 | University Of Massachusetts | Antibiotic prodrugs |
CN111704614A (en) * | 2020-04-15 | 2020-09-25 | 深圳大学 | A new series of immune agonists |
-
2021
- 2021-01-06 CN CN202110014657.3A patent/CN114716345A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6448256B1 (en) * | 1999-05-24 | 2002-09-10 | University Of Massachusetts | Antibiotic prodrugs |
CN111704614A (en) * | 2020-04-15 | 2020-09-25 | 深圳大学 | A new series of immune agonists |
Non-Patent Citations (5)
Title |
---|
ANDRZEJ MANIKOWSKI等: "Inhibition of Herpes Simplex Virus Thymidine Kinases by 2-Phenylamino-6-oxopurines and Related Compounds:Structure-Activity Relationships and Antiherpetic Activity in Vivo", J.MED.CHEM., vol. 48, pages 3919 - 3929 * |
CHENGXIN ZHI等: "Synthesis and Antibacterial Activity of 3-Substituted-6-(3-ethyl-4-methylanilino)uracils", J.MED.CHEM., vol. 48, pages 7063 - 7074 * |
GEORGE E.WRIGHT等: "Active site directed inhibitors of replication-specific bacterial DNA polymerases", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 15, pages 729 - 732 * |
SCOTT E.DENMARK等: "Iron-Catalyzed Cross-Coupling of Unactivated Secondary Alkyl Thio Ethers and Sulfones with Aryl Grignard Reagents", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 78, pages 12593 - 12628 * |
STUART W.HAYNES等: "Stereochemical Elucidation of Streptorubin B", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 133, pages 1793 - 1798 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007523213A (en) | Process for the preparation of pharmaceutically acceptable duloxetine salts and intermediates thereof | |
US8143453B2 (en) | Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis | |
CN102229551B (en) | A kind of preparation method of isothiocyanate | |
CN107488139B (en) | A kind of preparation method of sulfur-containing 3-aryl methylene isoindolinone derivative | |
CN107098834A (en) | A kind of preparation method of aromatic sulfinic acids class compound | |
CN114716345A (en) | Method for deoxygenation functionalization and deoxygenation activation of alcohols and alcohol-functionalized materials | |
CN103694153B (en) | The method of styracin and arylsulfinate Reactive Synthesis alkenyl sulfone compound | |
Henry et al. | One-pot ortho-amination of aryl C–H bonds using consecutive iron and copper catalysis | |
WO2020141195A1 (en) | Fluorine-containing compounds for use as nucleophilic reagents for transferring functional groups onto high value organic compounds | |
CN114478150A (en) | S-deuterated methyl-aryl sulfonyl thioester compound and synthesis method and application thereof | |
Okuma et al. | Three Component Reaction of Arynes with Cyclic Ethers and Active Methines: Synthesis of ω-Trichloroalkyl Phenyl Ethers | |
CN108863884B (en) | Method for synthesizing conjugated nitroene substituted series derivatives by using DAST reagent as elimination reagent | |
CN103554064B (en) | The preparation method of 3-hydroxyl oxygen heterocycle butane | |
WO2016039691A1 (en) | Catalysts for making chiral heterocyclic sulfoxides | |
WO2019178480A1 (en) | Pyrazole-containing macrophage migration inhibitory factor inhibitors | |
CN106349125B (en) | Utilize the method for manganese salt selectivity synthesis (E) vinyl sulfone compound | |
CN110105302B (en) | A kind of preparation method of benzoheterocyclic aromatic sulfide compound | |
CN113004178A (en) | Synthesis method of (E) -3-methylthio-2-iodoacrylate compound | |
WO2005100301A1 (en) | 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors | |
CN110240572B (en) | Synthesis method of trans-1, 1-cyclopropane dicarboxylic acid ester | |
CN109593068B (en) | Intermediate of ROR gamma inhibitor and preparation method thereof | |
CN111960975A (en) | Allyl thioether compound and preparation method thereof | |
CN108658934B (en) | Preparation method of 1, 2-disulfide-3-thioketone derivative synthesized by copper catalysis | |
EP3246309B1 (en) | Method for treating tin compound in reaction mixture | |
CN104788415A (en) | Method for asymmetrically synthesizing 4-nitromethyl-3-benzyl-3,4-dihydrocoumarin derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |